<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">96076</article-id><article-id pub-id-type="doi">10.7554/eLife.96076</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.96076.4</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Gliogenesis from the subventricular zone modulates the extracellular matrix at the glial scar after brain ischemia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ardaya</surname><given-names>Maria</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0103-5649</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="pa1">†</xref><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Tiveron</surname><given-names>Marie-Catherine</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Cremer</surname><given-names>Harold</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8673-5176</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund13"/><xref ref-type="other" rid="fund14"/><xref ref-type="other" rid="fund15"/><xref ref-type="other" rid="fund16"/><xref ref-type="other" rid="fund17"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Rubio-López</surname><given-names>Esther</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Martín</surname><given-names>Abraham</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Dehay</surname><given-names>Benjamin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1723-9045</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Pérez-Cerdá</surname><given-names>Fernando</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Matute</surname><given-names>Carlos</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8672-711X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Soria</surname><given-names>Federico N</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1229-9663</contrib-id><email>federico.soria@achucarro.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Cavaliere</surname><given-names>Fabio</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2003-522X</contrib-id><email>fabio.cavaliere@ehu.eus</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00myw9y39</institution-id><institution>Achucarro Basque Center for Neuroscience</institution></institution-wrap><addr-line><named-content content-type="city">Leioa</named-content></addr-line><country>Spain</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/000xsnr85</institution-id><institution>Department of Neuroscience, University of the Basque Country (UPV/EHU)</institution></institution-wrap><addr-line><named-content content-type="city">Leioa</named-content></addr-line><country>Spain</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00zca7903</institution-id><institution>CIBERNED</institution></institution-wrap><addr-line><named-content content-type="city">Madrid</named-content></addr-line><country>Spain</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035xkbk20</institution-id><institution>Aix Marseille University, CNRS, IBDM, Campus de Luminy</institution></institution-wrap><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/004g03602</institution-id><institution>CIC biomaGUNE, Basque Research and Technology Alliance (BRTA)</institution></institution-wrap><addr-line><named-content content-type="city">San Sebastian</named-content></addr-line><country>Spain</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cc3fy72</institution-id><institution>Ikerbasque, Basque Foundation for Science</institution></institution-wrap><addr-line><named-content content-type="city">Bilbao</named-content></addr-line><country>Spain</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057qpr032</institution-id><institution>University of Bordeaux, CNRS, IMN, UMR 5293</institution></institution-wrap><addr-line><named-content content-type="city">Bordeaux</named-content></addr-line><country>France</country></aff><aff id="aff8"><label>8</label><institution>Basque Biomodel Platform for Human Research (BBioH)</institution><addr-line><named-content content-type="city">Leioa</named-content></addr-line><country>Spain</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Scimemi</surname><given-names>Annalisa</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012zs8222</institution-id><institution>University at Albany, State University of New York</institution></institution-wrap><addr-line><named-content content-type="city">Albany</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Araújo</surname><given-names>Sofia J</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/021018s57</institution-id><institution>University of Barcelona</institution></institution-wrap><addr-line><named-content content-type="city">Barcelona</named-content></addr-line><country>Spain</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Donostia International Physics Center (DIPC), San Sebastian, Spain</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>19</day><month>08</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP96076</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-01-19"><day>19</day><month>01</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-01-20"><day>20</day><month>01</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.12.30.573719"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-03-13"><day>13</day><month>03</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.96076.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-10-14"><day>14</day><month>10</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.96076.2"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-01-20"><day>20</day><month>01</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.96076.3"/></event></pub-history><permissions><copyright-statement>© 2024, Ardaya et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Ardaya et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-96076-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-96076-figures-v1.pdf"/><abstract><p>Activation of the subventricular zone (SVZ) following cerebral ischemia is one of the brain’s early responses to counteract neuron loss and minimize tissue damage. Impaired brain regions communicate with the SVZ through various chemotactic signals that promote cell migration and differentiation, primarily involving neural stem cells, neuroblasts, or glioblasts. However, the activation of gliogenesis and the role of newly formed astrocytes in the post-ischemic scenario remain subjects of debate. We have previously demonstrated that adenosine release after brain ischemia prompts the SVZ to generate new astrocytes. Here, we used transient brain ischemia in mice to identify the cellular origin of these astrocytes within the SVZ neurogenic niche and investigate their role in the pathological process. By combining immunofluorescence, BrdU-tracing, and genetic cell labeling, we tracked the migration of newborn astrocytes, positive for the proteoglycan marker Thbs4, from the dorsal and medial SVZ to the perilesional barrier surrounding the ischemic core, known as the ‘glial scar’. We found that these Thbs4-positive astrocytes modulate the dense extracellular matrix at the lesion border by both synthesizing and degrading hyaluronan. We also show that while the accumulation of hyaluronan at the lesion site is sufficient to recruit newborn astrocytes, its degradation at the SVZ correlates with gliogenesis. These findings suggest that newborn astrocytes could be a promising pharmacological target for modulating the glial scar after brain ischemia and facilitating tissue regeneration.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>cell regeneration</kwd><kwd>astrocytes</kwd><kwd>MCAO</kwd><kwd>extracellular matrix</kwd><kwd>glial scar</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006251</institution-id><institution>University of Bordeaux</institution></institution-wrap></funding-source><award-id>IdEx 'Investments for the Future' program/GPR BRAIN_2030</award-id><principal-award-recipient><name><surname>Dehay</surname><given-names>Benjamin</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003086</institution-id><institution>Basque Government</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Cavaliere</surname><given-names>Fabio</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012440</institution-id><institution>Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa</institution></institution-wrap></funding-source><award-id>BIO21/COV/012</award-id><principal-award-recipient><name><surname>Cavaliere</surname><given-names>Fabio</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Eukampus</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Cavaliere</surname><given-names>Fabio</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004837</institution-id><institution>Ministerio de Ciencia e Innovación</institution></institution-wrap></funding-source><award-id>PRTR-C17.I1</award-id><principal-award-recipient><name><surname>Cavaliere</surname><given-names>Fabio</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004837</institution-id><institution>Ministerio de Ciencia e Innovación</institution></institution-wrap></funding-source><award-id>IJCI-2017-32114</award-id><principal-award-recipient><name><surname>Soria</surname><given-names>Federico N</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004837</institution-id><institution>Ministerio de Ciencia e Innovación</institution></institution-wrap></funding-source><award-id>PID2020-115896RJ-I00</award-id><principal-award-recipient><name><surname>Soria</surname><given-names>Federico N</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004837</institution-id><institution>Ministerio de Ciencia e Innovación</institution></institution-wrap></funding-source><award-id>RYC2021-032602-I</award-id><principal-award-recipient><name><surname>Soria</surname><given-names>Federico N</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003086</institution-id><institution>Basque Government</institution></institution-wrap></funding-source><award-id>IT-1203-19</award-id><principal-award-recipient><name><surname>Matute</surname><given-names>Carlos</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100015496</institution-id><institution>Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Matute</surname><given-names>Carlos</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003086</institution-id><institution>Basque Government</institution></institution-wrap></funding-source><award-id>PhD fellowship</award-id><principal-award-recipient><name><surname>Ardaya</surname><given-names>Maria</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004837</institution-id><institution>Ministerio de Ciencia e Innovación</institution></institution-wrap></funding-source><award-id>PCI2022-134986-2</award-id><principal-award-recipient><name><surname>Martín</surname><given-names>Abraham</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006424</institution-id><institution>Fédération pour la Recherche sur le Cerveau</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Cremer</surname><given-names>Harold</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR- 17-CE16-0025-02</award-id><principal-award-recipient><name><surname>Cremer</surname><given-names>Harold</given-names></name></principal-award-recipient></award-group><award-group id="fund15"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-21-CE16-0034-01</award-id><principal-award-recipient><name><surname>Cremer</surname><given-names>Harold</given-names></name></principal-award-recipient></award-group><award-group id="fund16"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-21-CE13-0003</award-id><principal-award-recipient><name><surname>Cremer</surname><given-names>Harold</given-names></name></principal-award-recipient></award-group><award-group id="fund17"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002915</institution-id><institution>Fondation pour la Recherche Médicale</institution></institution-wrap></funding-source><award-id>EQU201903007806</award-id><principal-award-recipient><name><surname>Cremer</surname><given-names>Harold</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A population of ischemia-induced newborn astrocytes, positive for Thbs4, that migrate to the lesion border, where they produce and degrade hyaluronan, modulating the local extracellular matrix, has been identified.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Cell regeneration in the adult mammalian brain primarily occurs in two neurogenic niches: the subventricular zone (SVZ) in the lateral ventricle and the subgranular zone (SGZ) in the dentate gyrus of the hippocampus (<xref ref-type="bibr" rid="bib9">Bond et al., 2015</xref>). Adult brain stem cells are multipotent and originate from the embryonic radial glia, thus sharing key cell markers and features with resident astrocytes. In the adult mouse brain, neuroblasts from SVZ migrate through the rostral migratory stream (RMS) to the olfactory bulb (OB), where neurogenesis takes place (<xref ref-type="bibr" rid="bib42">Luskin, 1993</xref>). Neuronal hyperactivity (e.g., during epilepsy), as well as pathological conditions (e.g., stroke) or natural (e.g., aging) processes, can impair the physiological functions of the neurogenic niches, altering their neurogenic and gliogenic potential (<xref ref-type="bibr" rid="bib19">Chaker et al., 2016</xref>; <xref ref-type="bibr" rid="bib34">Kralic et al., 2005</xref>; <xref ref-type="bibr" rid="bib55">Sundholm-Peters et al., 2005</xref>). For example, SVZ cells are known to become activated in vivo following focal ischemia induced by middle cerebral artery occlusion (MCAO) (<xref ref-type="bibr" rid="bib17">Ceanga et al., 2021</xref>).</p><p>We have previously demonstrated in oxygen and glucose-deprived (OGD) organotypic brain slices that the ischemic region and the SVZ establish a biochemical interplay based on a gradient of toxic and protective factors released early after the insult (<xref ref-type="bibr" rid="bib15">Cavaliere et al., 2006</xref>). Furthermore, others have demonstrated that brain stroke models in mice can activate astrogliogenesis at the expense of neurogenesis (<xref ref-type="bibr" rid="bib8">Benner et al., 2013</xref>; <xref ref-type="bibr" rid="bib36">Laug et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">Li et al., 2010</xref>). Benner and colleagues identified a SVZ-derived astrocyte population characterized by high levels of the membrane-bound proteoglycan thrombospondin 4 (Thbs4), a cell–cell and cell–matrix adhesion molecule that has been considered neuroprotective against ischemic damage (<xref ref-type="bibr" rid="bib8">Benner et al., 2013</xref>; <xref ref-type="bibr" rid="bib36">Laug et al., 2019</xref>). Ablation of Thbs4 in KO mice also produced abnormal ischemic scar formation and increased microvascular hemorrhage, suggesting a role of SVZ astrogliogenesis in brain damage and glial scar formation induced by ischemic stroke (<xref ref-type="bibr" rid="bib8">Benner et al., 2013</xref>).</p><p>The perilesional barrier known as the <italic>glial scar</italic> assembles early after brain ischemia, isolating the damaged area and limiting both the spread of pathogens and potentially toxic damage-associated molecular patterns (DAMPs) into the surrounding area (<xref ref-type="bibr" rid="bib2">Anderson et al., 2016</xref>; <xref ref-type="bibr" rid="bib12">Bush et al., 1999</xref>; <xref ref-type="bibr" rid="bib26">Faulkner et al., 2004</xref>). Consisting of packed reactive astrocytes and a dense extracellular matrix (ECM) composed mostly of hyaluronic acid (HA), the glial scar represents a physical barrier for the SVZ-generated newborn neurons that migrate into the ischemic core (<xref ref-type="bibr" rid="bib4">Arvidsson et al., 2002</xref>; <xref ref-type="bibr" rid="bib58">Yamashita et al., 2006</xref>). Thus, modulating glial scar formation after brain ischemia may be a strategy to reduce tissue damage and restore brain functionality. In ischemic stroke, the brain ECM goes through a significant reorganization due to injury and must undergo successful remodeling to promote brain repair. ECM elements involved in the ischemic cascade induce activation of astrocytes and microglia, which modulate ECM structure by releasing glycoproteins into the extracellular space (<xref ref-type="bibr" rid="bib1">Adams and Gallo, 2018</xref>; <xref ref-type="bibr" rid="bib28">Fawcett, 2015</xref>). This crosstalk culminates in the formation of the glial scar, which is created locally by reactive astrocytes and astrocytes-secreted ECM molecules such as HA and chondroitin sulphate proteoglycans (<xref ref-type="bibr" rid="bib12">Bush et al., 1999</xref>; <xref ref-type="bibr" rid="bib35">Lau et al., 2013</xref>).</p><p>We have previously demonstrated that high extracellular adenosine levels, a hallmark of ischemic insults, induce astrogliogenesis from the SVZ (<xref ref-type="bibr" rid="bib7">Benito-Muñoz et al., 2016</xref>). Following our previous results, here we characterize the SVZ response to brain ischemia and investigate the role of newly generated astrocytes in the modulation of the glial scar after MCAO. We show that ischemic conditions increase the number of newly generated astrocytes in the SVZ and their migration to the ischemic area. We also propose the role of these astrocytes in modulating the ECM at the glial scar and suggest this astrocyte population as a possible target for brain repair after brain ischemia.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Thbs4 is expressed in the neurogenic niche of the SVZ</title><p>As suggested by others (<xref ref-type="bibr" rid="bib8">Benner et al., 2013</xref>; <xref ref-type="bibr" rid="bib31">Girard et al., 2014</xref>; <xref ref-type="bibr" rid="bib46">Pous et al., 2020</xref>), Thbs4 is highly expressed in astrocytes of the SVZ and RMS and might play a role in ischemia-induced neurogenesis. To confirm these observations, we labeled the mouse SVZ by immunofluorescence for Thbs4. Thbs4 was mainly expressed in the SVZ, RMS, and OB but also in the cerebellum and ventral tegmental area (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). In the SVZ, the staining was associated with cells with different morphologies (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), ranging from cells with small primary apical processes in contact with the ventricle, to rounded NSC-like cells in the dorsolateral SVZ horn. After quantification by direct count of Thbs4-positive cells, Thbs4-positive astrocytes represented 21.4% of the total SVZ cells (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), with more than 60% of them displaying a radial glia-like type-B morphology (<xref ref-type="bibr" rid="bib9">Bond et al., 2015</xref>; <xref ref-type="bibr" rid="bib22">Doetsch et al., 1999</xref>; <xref ref-type="fig" rid="fig1">Figure 1D</xref>). This is in accordance with other studies reporting Thbs4 expression in B-cells, either by immunohistochemistry (<xref ref-type="bibr" rid="bib6">Beckervordersandforth et al., 2010</xref>; <xref ref-type="bibr" rid="bib8">Benner et al., 2013</xref>) or single-cell RNA sequencing (<xref ref-type="bibr" rid="bib5">Basak et al., 2018</xref>; <xref ref-type="bibr" rid="bib18">Cebrian-Silla et al., 2021</xref>; <xref ref-type="bibr" rid="bib40">Llorens-Bobadilla et al., 2015</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Thbs4 labels type-B cells in the subventricular zone (SVZ) neurogenic niche.</title><p>(<bold>A</bold>) Schematic drawing of the brain showing Thbs4 labeling throughout the mouse brain. Thbs4 was primarily found in the SVZ and rostral migratory stream (RMS) of the adult mouse telencephalon. Arrows indicate nonspecific Thbs4 staining in the cerebellum and ventral tegmental area. (<bold>B</bold>) Thbs4-positive cells in the SVZ displayed various morphologies. (<bold>C</bold>) Proportion of Thbs4-positive cells relative to the total neural stem cells (NSCs) population in the SVZ. (<bold>D</bold>) Classification of Thbs4-positive cells in the SVZ based on their NSC morphology. (<bold>E</bold>) Electroporation of pThbs4-GFP at P1 revealed Thbs4 expression in the postnatal dorsal SVZ. (<bold>F</bold>) Quantification of Thbs4-reporter expression showing the proportion of NSC expressing Thbs4 postnatally in the dorsal SVZ. (<bold>G</bold>) Thbs4-GFP reporter expression was upregulated in the rostral SVZ. BV: blood vessel; LV: lateral ventricle. Scale bar = 10 µm (<bold>B</bold>) and 50 µm (<bold>E</bold>). Bars represent mean ± SEM. *p&lt;0.05 and **p&lt;0.01, Tukey post hoc test (after one-way ANOVA was significant at p&lt;0.05).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig1-v1.tif"/></fig><p>To validate the immunohistochemistry protocol for Thbs4, we labeled the SVZ cells with green fluorescent protein (GFP) under the control of the Thbs4 promoter (pThbs4-eGFP) by postnatal (P1) electroporation (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Twenty-four hours after electroporation, almost 20% of total cells in the dorsal SVZ expressed GFP (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), with a greater expression in the rostral SVZ (<xref ref-type="fig" rid="fig1">Figure 1G</xref>), confirming that Thbs4-positive cells were mainly localized in the neurogenic niche of the SVZ. This also suggests that Thbs4 is expressed in NSCs at early postnatal stages, generating astrocytes during development.</p></sec><sec id="s2-2"><title>Thbs4 expression in the SVZ increases after brain ischemia</title><p>To investigate whether brain ischemia could activate astrogliogenesis in the SVZ, we analyzed cell proliferation and Thbs4 expression in the SVZ after MCAO (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Sixty minutes of MCAO (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>) caused neuronal damage in the cortex and striatum, as observed by cresyl violet staining and NeuN immunofluorescence (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B and C</xref>). The survival rate at 28 days post-lesion was around 50% (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). Moreover, motor deficits and animal weight of ischemic mice were monitored every day after MCAO for 30 days. Motor deficits improved over time, while body weight dropped sharply the first 3 days after MCAO and was partially restored at 30 dpi (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E and F</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Thbs4 expression is upregulated in the subventricular zone (SVZ) after brain ischemia.</title><p>(<bold>A</bold>) Representative images of Thbs4 (green), Nestin (red), and doublecortin (DCX) (magenta) in the SVZ under physiological conditions (left) and 15 days post-injury (dpi) (right). (<bold>B, C</bold>) The number of actively proliferating neural stem cells (NSCs) and neuroblasts decreases at 7 and 15 dpi in the SVZ, as shown by reduced Nestin (<bold>B</bold>) and DCX (<bold>C</bold>) levels, respectively. (<bold>D</bold>) Thbs4 expression increases in the SVZ over time following ischemic injury. (<bold>E</bold>) Representative western blot images of Nestin and Thbs4 in sham and 15 dpi SVZ. (<bold>F, G</bold>) Quantification of mean gray value (MGV) from (<bold>E</bold>), normalized to GAPDH, shows an increase in Thbs4 (<bold>F</bold>) and a decrease in Nestin (<bold>G</bold>) in the 15 dpi SVZ. Scale bar = 100 µm in (<bold>A</bold>). n=6 (<bold>B</bold>–<bold>D</bold>) and 3 (<bold>E</bold>–<bold>G</bold>) per condition. Bars represent mean ± SEM. *p&lt;0.05 and **p&lt;0.01; two-tailed Student’s <italic>t</italic>-test (sham vs. 15ddMCAO) and Tukey post hoc test (after one-way ANOVA was significant at p&lt;0.05).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Full uncut blots (annotated) for <xref ref-type="fig" rid="fig2">Figure 2E</xref>.</title></caption><media mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig2-data1-v1.tif"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Raw uncut blot files.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-96076-fig2-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Characterization of the middle cerebral artery occlusion (MCAO) mouse model of brain ischemia.</title><p>(<bold>A</bold>) Scheme of the procedure: 10 mm silicon-coated filament was inserted through an external artery and re-directed to the internal one. Ischemia was induced after 60 minutes of occlusion. After that, the filament was removed, and animals were observed every day before euthanasia. (<bold>B</bold>) Volume of infarction was observed by cresyl violet staining. (<bold>C</bold>) Neuronal death was observed by NeuN immunofluorescence. (<bold>D</bold>) Around 50% of ischemic mice survived at 28 dpi. (<bold>E</bold>) Ischemic animals ameliorated neurological symptoms over time. (<bold>F</bold>) Weight was measured as controls for mice healthcare. n=17 (D–F). **p&lt;0.01 and ****p&lt;&lt;0.0001 by survival curve test and Tukey post hoc test (after one-way ANOVA was significant at p&lt;0.05).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Cell proliferation in the subventricular zone (SVZ) after brain ischemia.</title><p>(<bold>A</bold>) Experimental design: three BrdU (50 mg/kg) injections were performed the day before middle cerebral artery occlusion (MCAO) protocol. Animals were sacrificed 24 hours after the brain stroke model. (<bold>B</bold>) BrdU-positive cells increased in the SVZ 24 hours after MCAO. (<bold>C</bold>) Representative image of BrdU-positive cells in the ipsilateral (left) and contralateral (right) hemisphere 24 hours after MCAO. (<bold>D</bold>) Ki67 marker was also used to analyze cell proliferation in wholemount preparations of the SVZ. (<bold>E</bold>) Ki67-positive cells increased in the SVZ 24 hours after MCAO. (<bold>F</bold>) The Cleaved-Caspase 3 marker increased in the SVZ 24 hours after MCAO. (<bold>G</bold>) Cleaved-caspase 3 marker was used to assess apoptosis in the SVZ after brain ischemia. Scale bar = 15 µm (<bold>G</bold>). n=5 (sham) and 4 (MCAO). Bars represent mean ± SEM. *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001 by two-tailed Student’s <italic>t</italic>-test (sham vs. 24h MCAO).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig2-figsupp2-v1.tif"/></fig></fig-group><p>To study cell proliferation in the SVZ, we administered 50 mg/kg BrdU i.p. every 2 hours (three doses in total) the day before MCAO (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). We observed an increase in the number of total SVZ BrdU-positive cells 24 hours after MCAO (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B and C</xref>). Ki67 immunofluorescence of SVZ wholemount preparations also revealed a more than tenfold increase of proliferative cells 24 hours after MCAO (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D and E</xref>). In addition, we observed a significant increase in cleaved Caspase3-positive cells 24 hours post-lesion (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2F and G</xref>). These results suggest a fast and specific proliferative response in the ischemia-induced SVZ.</p><p>We next analyzed Thbs4 staining in combination with Nestin, an NSC marker, and doublecortin (DCX), a marker of neuroblasts, before and after MCAO. The entire SVZ was analyzed in sham and ischemic mice 7, 15, and 30 days post-ischemia (dpi). The immunofluorescence analysis of the SVZ (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) showed a transient decrease in Nestin and DCX-positive cells but an increase of Thbs4-positive astrocytes up to 15 dpi (<xref ref-type="fig" rid="fig2">Figure 2B–D</xref>) compared to sham animals. The increase of Thbs4 astrocytes was also confirmed by western blot analysis using SVZ homogenates (<xref ref-type="fig" rid="fig2">Figure 2E and F</xref>), evidencing a twofold increased expression of Thbs4 in the ischemic SVZ. Similarly to immunofluorescence, western blot also showed decreased Nestin protein levels at 15 dpi (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). These results demonstrate that Thbs4 expression in the SVZ increases after ischemia, coinciding with a decrease in neuroblast markers, suggesting that the classical pro-neuroblast program of the SVZ is interrupted in favor of the generation of astrocytes after ischemia.</p></sec><sec id="s2-3"><title>Characterization of ischemia-induced cell populations in the SVZ</title><p>To characterize the different cell populations of the SVZ activated after focal ischemia, we labeled the whole pool of proliferating cells with 1% BrdU in drinking water for 14 days before MCAO (<xref ref-type="bibr" rid="bib20">Codega et al., 2014</xref>). One month after MCAO, BrdU in the SVZ primarily stained slow proliferative cells like type B cells, whereas in rapid transit-amplifying cells (type C), BrdU was diluted away. Therefore, we chose to label type C cells by intraperitoneal administration (50 mg/kg) of 5-Iodo-2′-deoxyuridine (IdU) 24 hours before euthanasia (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). To identify the cellular origin of newborn astrocytes, we analyzed the SVZ 30 dpi by immunofluorescence co-labeling Thbs4 and GFAP together with BrdU or IdU. We found a twofold increase in the total amount of proliferative cells (BrdU-positive) after MCAO with respect to the sham group (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), whereas we did not observe a significant change in the number of IdU-positive cells (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). The number of slow proliferative NSC (Thbs4/GFAP/BrdU) increased linearly after MCAO (<xref ref-type="fig" rid="fig3">Figure 3D and E</xref>), especially in the dorsal region of the SVZ (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>), whereas the number of activated NSC (Thbs4/GFAP/IdU) did not change significantly, either in the whole SVZ (<xref ref-type="fig" rid="fig3">Figure 3F</xref>) or in any subregion analyzed (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). These results suggest that, after ischemia, Thbs4-positive astrocytes derive from the slow proliferative type B cells.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Thbs4-positive cells derive from type B neural stem cells (NSCs) in the subventricular zone (SVZ) after brain ischemia.</title><p>(<bold>A</bold>) Experimental design: chronic BrdU (1% in water) treatment was administered for 2 weeks. BrdU labeling persisted only in B type NSCs 30 days after treatment. Animals were injected with IdU (50 mg/kg) three times the day before euthanasia to label proliferating cells. (<bold>B</bold>, <bold>C</bold>) BrdU (<bold>B</bold>) and IdU (<bold>C</bold>)-positive cells in the SVZ. Only BrdU-positive cells showed a significant increase at 30 dpi. (<bold>D</bold>) Representative confocal images showing Thbs4, GFAP, and BrdU levels in sham (top) and 30 dpi mice (bottom). (<bold>E</bold>, <bold>F</bold>) Thbs4/GFAP/BrdU-positive cells (slow proliferative cells) increased in the SVZ at 30 dpi (<bold>E</bold>), while no changes were observed in Thbs4/GFAP/IdU-positive cells (fast proliferative cells). Scale bar = 20 µm (<bold>D</bold>). n=4 (sham) and 3 (MCAO). Bars represent mean ± SEM. *p&lt;0.05 by two-tailed Student’s <italic>t</italic>-test (sham vs. 30dd MCAO).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Thbs4 astrocytes derive from slow proliferative cells after brain ischemia.</title><p>(<bold>A</bold>) Slow proliferative cells were quantified in the lateral (gray), ventral (orange), medial (yellow), and dorsal (blue) subventricular zone (SVZ). We only observed an increase of Thbs4/GFAP/BrdU-positive cells in the dorsal SVZ 30 dpi. (<bold>B</bold>) Thbs4/GFAP/IdU-positive cells did not show changes in the lateral (gray), ventral (orange), medial (yellow), and dorsal (blue) SVZ after brain ischemia. n=4 (sham) and 3 (MCAO). **p&lt;0.01 by two-tailed Student’s <italic>t</italic>-test (sham vs. 30dd MCAO).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig3-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Ischemia-induced newborn astrocytes migrate from the dorsal SVZ to ischemic regions</title><p>To confirm that Thbs4-positive astrocytes originate from type B cells of dorsal SVZ, we labeled NSCs of dorsal SVZ by electroporating the pCAGGSx-CRE plasmid in P1 Ai14 Rosa26-CAG-tdTomato transgenic mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Plasmid electroporation induced the expression of tdTomato (tdTOM) by Cre recombination, enabling the spatial tracking and cell fate assessment of electroporated NCSs from the dorsal SVZ. Three to four months after electroporation, we performed the MCAO, and tdTOM fluorescence was analyzed at 7, 30, and 60 dpi. To confirm the efficient labeling of NSCs by the electroporation protocol, we followed the tdTOM fluorescence in the OB (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>, see ‘Materials and methods’). Only those animals with tdTOM-positive cells in the OB were taken into account for later analysis. After quantification of tdTOM-positive NSCs 7, 30, and 60 dpi, we observed a significant decrease in tdTOM-positive cells in ischemic animals in all SVZ regions analyzed (<xref ref-type="fig" rid="fig4">Figure 4B and C</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>), suggesting that they either left the area or died. Conversely, there was a general increase of tdTOM-positive cells outside the SVZ (<xref ref-type="fig" rid="fig4">Figure 4D and E</xref>), especially in the intermediate and caudal axis of the whole brain compared to sham animals (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C–F</xref>), suggesting that electroporated cells had migrated away from the SVZ.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Ischemia-induced Thbs4 astrocytes migrate from the subventricular zone (SVZ) to ischemic areas.</title><p>(<bold>A</bold>) Experimental design: Ai14, ROSA26-CAG-tdTomato transgenic mice were electroporated in the dorsal SVZ at P1. The pCAGGSx-CRE plasmid induced tdTomato (tdTOM) expression in dorsal neural stem cells (NSCs). Middle cerebral artery occlusion (MCAO) was performed 3–4 months later in the same electroporated hemisphere. Mice were analyzed at 7, 30, and 60 dpi. (<bold>B</bold>) Quantification of tdTOM-positive cells shows a decrease in the dorsal SVZ following brain ischemia. (<bold>C</bold>) Representative images of tdTOM-positive cells in sham (top) and 60 dpi SVZ (bottom). (<bold>D</bold>) Quantification of tdTOM-positive cells in the whole brain shows a gradual increase outside the SVZ after brain ischemia. (<bold>E</bold>) Representative images of tdTOM expression in sham (left) and 60 dpi mice (right). (<bold>F</bold>) Representative image of Thbs4/tdTOM-positive cells in the dorsal SVZ. (<bold>G</bold>) Quantification shows an increase in Thbs4/tdTOM-positive cells in the SVZ at 30 and 60 dpi. (<bold>H</bold>) The proportion of Thbs4-positive cells within the tdTOM-positive pool increases in the SVZ at 30 and 60 dpi. (<bold>I</bold>) Around 50% of tdTOM-positive cells expressed Thbs4 in the infarcted tissue at 60 dpi. (<bold>J</bold>) Representative image of Thbs4 and tdTOM expression near the damaged area. Scale bar = 50 µm (<bold>C</bold>), 100 µm (<bold>E, J</bold>), and 10 µm (<bold>F</bold>). n=6 animals per condition. Bars represent mean ± SEM. *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001 by chi-square test (<bold>H</bold>) and Tukey post hoc test (after one-way ANOVA was significant at p&lt;0.05).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Ischemic-induced Thbs4 astrocytes migrate preferentially to caudal infarcted areas.</title><p>(<bold>A</bold>) Representative image of tdTOM-positive cells in the olfactory bulb (OB) 3 weeks after electroporation (3wpi). (<bold>B</bold>) tdTOM-positive cells decreased in the rostral, intermediate, and caudal subventricular zone (SVZ) 7, 30, and 60 dpi. (<bold>C</bold>) Expression of tdTomato increased in intermediate and caudal brain areas at 30 dpi. (<bold>D</bold>) Representative images of tdTOM expression in rostral (left), intermediate (middle), and caudal (right) brain areas of sham (top) and 60 dpi mice (bottom). (<bold>E</bold>) tdTOM-positive cells increased in the infarcted cortex (Ctx) and striatum (Str) whereas decreased in the dorsal SVZ (SVZ). No changes were observed in the corpus callosum (CC). (<bold>F</bold>) tdTOM-positive cells only increased in the infarcted cortex and striatum at intermediate and caudal brain regions. (<bold>G</bold>) Thbs4/tdTOM-positive cells increased in rostral and intermediate SVZ 30 and 60 dpi. Scale bar = 100 µm (<bold>A, D</bold>). n=6 animals per condition. Bars represent mean ± SEM. *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001 by Dunnett/Tukey post hoc test (after two-way ANOVA was significant at p&lt;0.05).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig4-figsupp1-v1.tif"/></fig></fig-group><p>To identify the proportion of NSCs that differentiated into Thbs4-positive astrocytes following ischemia, we analyzed the co-expression of Thbs4 with tdTOM after MCAO. Despite the general decrease of tdTOM-positive cells in the SVZ, the fraction of Thbs4/tdTOM cells increased at 30 dpi after MCAO (<xref ref-type="fig" rid="fig4">Figure 4F and G</xref>), reaching a maximum increase at 60 dpi (<xref ref-type="fig" rid="fig4">Figure 4H</xref>), in particular in rostral and intermediate SVZ (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G</xref>). Finally, we analyzed the Thbs4-positive astrocytes recruitment to the ischemic regions. More than half of the total tdTOM-positive cells in the infarcted area expressed the Thbs4 marker at 60 dpi (<xref ref-type="fig" rid="fig4">Figure 4I and J</xref>). These results suggest that ischemia-induced astrogliogenesis in the SVZ occurs in type B cells from the dorsal region and that these newborn Thbs4-positive astrocytes migrate to the ischemic areas.</p></sec><sec id="s2-5"><title>Thbs4-positive astrocytes accumulate at the glial scar after brain ischemia</title><p>Besides its role in the neurogenic niches, Nestin is also rapidly and locally expressed by reactive astrocytes and participates in glial scar formation (<xref ref-type="bibr" rid="bib29">Frisén et al., 1995</xref>). Thus, we used Nestin immunofluorescence as a reliable tool to identify the lesion border where the glial scar occurs (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Nestin staining of the scar was also compared with more classical methodologies like TTC staining (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), where viable tissue is stained red and dead tissue is left unstained. The white-pale pink area was then measured as infarct tissue by TTC staining (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Unlike the TTC staining, which can only be performed shortly after the lesion, the visualization of the glial scar with Nestin immunofluorescence allowed us to analyze the lesion at later time points. We observed a rapid formation of the glial scar as early as 7 dpi (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Analyzing the expression of the two astrocytic markers, Thbs4 and GFAP, as a percentage of the glial scar region of interest (ROI), we observed different dynamics and localization. GFAP expression increased rapidly after 7 days within the glial scar ROI, whereas Thbs4 was upregulated at 15 dpi (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). This delay suggested that the glial scar harbors two different astrocytic subpopulations: GFAP-only or GFAP/Thbs4. To analyze the spatial location of GFAP and Thbs4 markers within the Nestin border, we measured the fluorescence intensity profile of damaged area at 30 dpi. GFAP was found in both the scar and core areas, whereas Thbs4 fluorescence was found mostly at the borders of the glial scar (<xref ref-type="fig" rid="fig5">Figure 5F and G</xref>). Analysis and dynamics of Thbs4-positive astrocyte migration were further performed in the corpus callosum (CC), striatum (Str), cortex (Ctx), and OB (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). We observed a linear increase of Thbs4-positive astrocytes from 7 to 60 dpi, both in the Ctx and Str (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). Migration occurred mainly through the corpus callosum; among the total GFAP-positive astrocytes, 36.5% were also positive for Thbs4, suggesting that more than one-third of the astrocytes in the glial scar originated from the SVZ (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). Likewise, the number of DCX-positive cells dramatically decreased 15 dpi in all OB layers (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D–F</xref>) together with a significant decrease of BrdU-positive cells and DCX/BrdU-positive neuroblasts in the RMS (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1G and H</xref>). This suggests that ischemia induced a change in the neuroblasts’ ectopic migratory pathway, depriving the OB layers of SVZ newborn neurons.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Ischemia-induced Thbs4 astrocytes accumulate at the glial scar.</title><p>(<bold>A</bold>) The glial scar could be observed at 30 dpi using Nestin immunofluorescence. (<bold>B</bold>) Classical TTC technique underestimated ischemic regions compared with Nestin immunofluorescence. (<bold>C</bold>) Representative images of TTC staining in infarcted brains. (<bold>D</bold>) Representative confocal images showing the time course of Nestin expression at 3, 7, 15, and 30 dpi. (<bold>E</bold>) The Nestin-positive glial scar was established by 15 dpi, while Thbs4 astrocytes arrived at the glial scar later, by 30 dpi. (<bold>F</bold>) Fluorescence profile of Thbs4, GFAP, and Nestin marker from the core to penumbra areas showed Thbs4 was mainly located at the borders of the Nestin-positive glial scar. (<bold>G</bold>) Representative images of Thbs4 (green), GFAP (white), and Nestin (red) markers in 30 dpi mice. Scale bar = 50 µm (<bold>D</bold>, <bold>G</bold>). n=3 animals per condition. Bars/lines represent mean ± SEM. *p&lt;0.05 and **p&lt;0.01 by two-tailed Student’s <italic>t</italic>-test (TTC vs. Nestin) and by Dunnett post hoc test (after two-way ANOVA was significant at p&lt;0.05).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Subventricular zone (SVZ) neural stem cells (NSCs) stop producing newborn neurons to send newborn astrocytes to the ischemic areas.</title><p>(<bold>A</bold>) Thbs4 expression in the corpus callosum (cc), infarcted cortex (Ctx), and infarcted striatum (Str) of sham and 7 and 30 dpi mice. (<bold>B</bold>) Thbs4 increased by 30 dpi in the cc and 60 dpi in the Ctx and Str. (<bold>C</bold>) Expression of Thbs4 increased in total GFAP population after 15, 30, and 60 dpi. (<bold>D</bold>) Experimental design: chronic BrdU (1% in water) treatment was administered for 2 weeks. BrdU only persisted in slow proliferative NSC (<xref ref-type="bibr" rid="bib20">Codega et al., 2014</xref>). Doublecortin (DCX) and BrdU-positive cells were measured in the olfactory bulb (OB) layers 7, 15, and 30 dpi. (<bold>E</bold>) Representative images of BrdU and DCX marker in sham (left), 15 (middle), and 30 (right) dpi mice OB. (<bold>F</bold>) DCX-positive cells decreased 15 and 30 dpi in the rostral migratory stream (RMS), granular OB layer (GrL), and glomerular OB layer (GL). (<bold>G</bold>) BrdU-positive cells only decreased 30 dpi in the glomerular OB layer (GL). Double DCX/BrdU-positive cells significantly decreased in the RMS 30 dpi. In (<bold>G</bold>) and (<bold>G</bold>), values are normalized to total DAPI nuclei (100%). Scale bar = 500 µm (<bold>A</bold>). n=6 animals per condition. Lines represent mean ± SEM. *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001 by chi-square test and Tukey post hoc test (after two-way ANOVA was significant at p&lt;0.05).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig5-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Thbs4-positive astrocytes modulate extracellular matrix homeostasis at the glial scar</title><p>To investigate the role of Thbs4-positive astrocytes in the glial scar, we analyzed HA, the main component of the brain ECM, using the hyaluronic acid binding protein (HABP) as a marker. Following ischemic damage, local astrocytes (GFAP+/Thbs4-) react by adopting a fibrotic morphology, producing high-molecular weight HA (HMW-HA) to form the glial scar and isolate the damaged area (<xref ref-type="bibr" rid="bib47">Preston and Sherman, 2011</xref>). We then examined HA deposition in the corpus callosum and the infarcted areas after MCAO. HABP immunofluorescence (<xref ref-type="fig" rid="fig6">Figure 6A</xref>) and image analysis revealed HA accumulation in the infarcted areas. Skeleton analysis, which quantifies the length of HA chains and correlates with its molecular weight, identified progressively longer HA cable-like structures at the glial scar as the infarct evolved (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Fractal dimension analysis, which reflects the interconnectivity of the ECM (<xref ref-type="bibr" rid="bib53">Soria et al., 2020</xref>), further confirmed HA accumulation and increased matrix complexity in infarcted areas, but not in corpus callosum (<xref ref-type="fig" rid="fig6">Figure 6C</xref>), suggesting that ECM accumulation is different in white and gray matter.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Thbs4-positive astrocytes produce hyaluronan at the glial scar after middle cerebral artery occlusion (MCAO).</title><p>(<bold>A</bold>) Representative images of hyaluronic acid (HA) labeled with HABP in the contralateral (1) and ipsilateral hemisphere (2). Only perineuronal nets are clearly visible in the healthy tissue, while a dense interstitial matrix is observed in ischemic areas. (<bold>B</bold>) Cumulative distribution of skeletonized HA signal in sham and infarcted regions of 7, 15, and 30 dpi mice (p&lt;0.0001). (<bold>C</bold>) Quantification of fractal dimension showed increased extracellular matrix interconnectivity in the infarcted cortex and striatum (Ctx and Str) at 30 dpi. (<bold>D</bold>) Representative confocal images of Thbs4 (green) and HABP (red) in the cortex and striatum of sham and 30 dpi mice. Note the HA labeling on the surface of Thbs4-positive cells. (<bold>E</bold>) Fluorescence intensity profile of Thbs4, GFAP, and HABP markers from the lesion core to penumbra areas. Thbs4 expression was mainly restricted to the borders of the HA-positive glial scar at 30 dpi. (<bold>F</bold>) Representative confocal images of Thbs4 and HABP markers in sham and 30 dpi mice (top). Examples of HA (red) occupying the membrane mask of Thbs4-positive astrocytes in sham and 30 dpi mice (bottom), showing increased HA synthesis after MCAO. (<bold>G</bold>) Quantification of membrane-bound HA showed increased HA along Thbs4-positive membrane after brain ischemia (corpus callosum: pink; infarcted cortex: blue; infarcted striatum: green). Scale bar = 500 µm (<bold>A</bold>), 10 µm (inset in <bold>A</bold>, <bold>D</bold>, and <bold>F</bold>). n=6 animals per condition. *p&lt;0.05 and ****p&lt;0.0001 by Kruskal–Wallis test and two-way ANOVA (significant at p&lt;0.05).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Thbs4 astrocytes internalize hyaluronic acid (HA) in the infarcted areas.</title><p>(<bold>A</bold>) Representative images of Thbs4/GFAP (‘newborn astrocytes’, top) and GFAP-only (‘local astrocytes’, bottom) cells in the infarcted areas at 30 dpi. (<bold>B</bold>) Thbs4-positive astrocytes internalized more HA compared to local astrocytes only labeled with GFAP marker. (<bold>C</bold>) However, the number of HA spots internalized was higher in local astrocytes compared with Thbs4 astrocytes, suggesting that Thbs4 internalizes HA in fewer vesicles. (<bold>D</bold>) Representative images of HABP (red), Thbs4 (green), and CD44 (blue) at the lesion border. Inset shows an orthogonal projection of Thbs4/CD44/HABP-positive intracellular vesicle. (<bold>E</bold>) Thbs4-positive astrocytes expressed a high rate of CD44 receptors so much in corpus callosum (CC), infarcted cortex (Ctx) as in infarcted striatum (Str). Scale bar = 10 µm (<bold>A, D</bold>). n=5 animals per condition. Bars represent mean ± SEM. *p&lt;0.05 and **p&lt;0.01 by Tukey post hoc test (after two-way ANOVA was significant at p&lt;0.05) and two-tailed Student’s <italic>t</italic>-test (Thbs4 vs. GFAP).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>In vitro neural stem cell (NSC)-derived Thbs4 cells synthesize hyaluronic acid (HA) after a hypoxic-ischemic condition.</title><p>(<bold>A</bold>) Experimental design: P4 pup rats were sacrificed, and subventricular zone (SVZ) NSC were extracted and cultured in the proliferative medium for 1 week. After that, neurospheres were disaggregated and seeded isolated in a culture dish. The following day, oxygen and glucose deprivation protocol (OGD) was performed. Cells were fixed 7 days after culturing them. (<bold>B</bold>) Representative images of in vitro Thbs4-positive cells (green) and HA (red). (<bold>C</bold>) HA spots were measured inside and outside Thbs4-positive cells. (<bold>D</bold>) HA spots increased inside Thbs4-positive astrocytes after OGD, whereas (<bold>E</bold>) decreased in the extracellular space. However, when NSCs were exposed to hyaluronidases in order to remove extracellular HA, Thbs4-positive cells decreased internalization of HA spots (<bold>F</bold>) and increased extracellular HA spots (<bold>G</bold>). (<bold>H</bold>) Neurosphere-derived NSC (NSPH1) internalized more HA spots compared with Iba1-positive cells. (<bold>I</bold>) Metalloproteinase activity was higher in OGD NSC cultures compared to control condition. Scale bar = 10 µm (<bold>b</bold>). n=15 samples per condition. Bars represent mean ± SEM. *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001 by two-tailed Student’s <italic>t</italic>-test (CTRL vs. OGD; NSPH1 vs. Iba1<sup>+</sup>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig6-figsupp2-v1.tif"/></fig></fig-group><p>The proximity of Thbs4-positive astrocytes to HA in the ischemic scar (<xref ref-type="fig" rid="fig6">Figure 6D and E</xref>) led us to investigate if this population contributed to ECM production and, consequently, to scar formation. Since HA is produced exclusively at the cell membrane (<xref ref-type="bibr" rid="bib50">Sherman et al., 2015</xref>; <xref ref-type="bibr" rid="bib60">Zimmermann and Dours-Zimmermann, 2008</xref>), we analyzed HA labeling within 1 µm of the Thbs4-positive cell membrane in high-resolution confocal images (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). Image analysis showed a significant increase in HABP area at Thbs4-positive astrocyte-cell membranes after MCAO (<xref ref-type="fig" rid="fig6">Figure 6G</xref>), suggesting a role of Thbs4-positive astrocytes in HA production within the glial scar.</p><p>To explore the potential role of Thbs4-positive astrocytes in HA removal, we quantified intracellular HABP spots in Thbs4-positive astrocytes at the glial scar. While HMW-HA cleavage occurs extracellularly, HA fragments can be internalized for degradation by lysosomal hyaluronidases (<xref ref-type="bibr" rid="bib47">Preston and Sherman, 2011</xref>; <xref ref-type="bibr" rid="bib60">Zimmermann and Dours-Zimmermann, 2008</xref>). Intracellular HABP spots were compared between Thbs4-positive astrocytes and local astrocytes (GFAP-positive/Thbs4-negative) (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). Thirty days after MCAO, Thbs4-positive astrocytes showed more intracellular HABP than local astrocytes in the infarcted cortex (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). However, the number of HA spots internalized was higher in local astrocytes compared with Thbs4 astrocytes (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>), suggesting that Thbs4-positive cells internalize HA in fewer vesicles. To confirm that astrocytes were degrading HA, we performed an immunofluorescence analysis of CD44 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>). CD44 is a transmembrane glycoprotein receptor that mediates HA internalization and degradation, and therefore ECM remodeling (<xref ref-type="bibr" rid="bib23">Dzwonek and Wilczynski, 2015</xref>). We detected that around 50% of the total Thbs4-positive astrocytes contained internalized CD44 receptor in the striatum 30 dpi (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>), with higher numbers (60%) for the infarcted corpus callosum. These findings suggest that Thbs4-positive astrocytes participate in both the formation and degradation of the ECM at the glial scar.</p><p>To further investigate HA internalization by astrocytes, we conducted in vitro experiments using cultures of rat SVZ neural stem cells, a more versatile preparation that displays the same HA internalization and degradation machinery as mouse brain tissue (<xref ref-type="bibr" rid="bib50">Sherman et al., 2015</xref>). An oxygen and glucose deprivation (OGD) protocol was applied as an ischemia model and cells were fixed 7 days after OGD (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref>). HA was analyzed via HABP immunofluorescence, both inside and outside the Thbs4-positive cells (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B and C</xref>). Thbs4-positive cells showed increased intracellular HA after OGD, while extracellular HA levels decreased (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2D and E</xref>). However, this phenomenon was reversed after adding hyaluronidases in the extracellular space (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2F and G</xref>), suggesting that Thbs4-positive cells from SVZ homogenates can internalize or synthesize HA depending on external stimuli. HA internalization was also measured in Iba1-positive cell cultures where we observed a reduced internalization compared to Thbs4-positive cells (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2H</xref>). Lastly, metalloproteinase activity was found to be increased in Thbs4 cultures following OGD (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2I</xref>). Altogether, these results suggest Thbs4-positive cells can internalize HA after ischemic conditions but also synthesize it when ECM is degraded.</p></sec><sec id="s2-7"><title>Hyaluronan accumulation is sufficient but not exclusive for the recruitment of Thbs4-positive astrocytes</title><p>Since Thbs4-positive astrocytes migrate to the glial scar but not to the ischemic core, we hypothesized that HA, the primary component of the ischemic scar, may be the trigger signal for recruiting Thbs4-positive astrocytes. To test this hypothesis, we simulated the ECM accumulation that occurs at the scar by overexpressing the Hyaluronan synthase 2 (Has2) from the naked mole rat (<italic>Heterocephalus glaber</italic>), a tool often used in mice to produce HA of very high molecular weight (<xref ref-type="bibr" rid="bib56">Tian et al., 2013</xref>; <xref ref-type="bibr" rid="bib59">Zhang et al., 2023</xref>). We used a viral vector (AAV2/9-CAG-Has2-3xFlag) with a FLAG tag to visualize transduced cells after intracerebral inoculation in the striatum and checked HA accumulation in FLAG-positive areas using HABP staining (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). We overexpressed Has2 (or GFP as control) unilaterally. In a subset of animals that underwent MCAO, AAV-Has2 was injected contralateral to the infarct, to compare Thbs4-positive astrocytes recruitment by both stimuli, the inflammation from the ischemic damage and the HA accumulation per se (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). FLAG-positive cells were quantified as a surrogate marker of viral infection for both control and MCAO groups (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). The GFP control group did not increase HA production per se (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). However, HA overexpression was observed in Has2 groups (both control and MCAO group) by HABP immunofluorescence (<xref ref-type="fig" rid="fig7">Figure 7E and F</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Hyaluronan accumulation is sufficient but not exclusive to recruit Thbs4 astrocytes.</title><p>(<bold>A</bold>) Representative images of hyaluronic acid (HA) accumulation caused by viral-mediated overexpression of Has2 from naked mole rat. (<bold>B</bold>) Experimental design: Has2 viral injections were performed 2 weeks before middle cerebral artery occlusion (MCAO). Animals were sacrificed 30 days after MCAO. We used standard GFP virus as control. Two groups of Has2-injected mice were studied, with only one subjected to MCAO. (<bold>C</bold>) FLAG-positive cells (Has2 virus tag) did not show changes in either Has2 control (Has2Control) or Has2-MCAO group (contralateral hemisphere). (<bold>D</bold>–<bold>F</bold>) Representative images of HABP, GFP, and Thbs4 markers in GFP control virus (<bold>D</bold>), HAS2 control virus (<bold>E</bold>), and Has2 MCAO group (<bold>F</bold>). (<bold>G</bold>) Thbs4 expression increased after Has2 viral-mediated overexpression. However, Thbs4 was upregulated in the ischemic hemisphere when MCAO was performed together with the Has2 viral infection (MCAO ipsi). GFP control virus did not induce an increase of Thbs4. (<bold>H</bold>) HABP was used as a control for HA accumulation. Thbs4 astrocytes in Has2 MCAO group increased in the ischemic hemisphere even though HA accumulation in both hemispheres (HAS2 and MCAO hemisphere), suggesting additional ischemia-induced signals recruit Thbs4 astrocytes to infarcted areas. Scale bar = 100 µm (<bold>A, F</bold>). n=6 animals per condition. *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001 by two-tailed Student’s <italic>t</italic>-test (Has2Control vs. MCAO Contra) and Tukey post hoc test (after one-way ANOVA was significant at p&lt;0.05).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig7-v1.tif"/></fig><p>HA accumulation was sufficient to recruit the Thbs4-positive astrocytes from the ipsilateral SVZ 45 days after AAV-Has2 inoculation (<xref ref-type="fig" rid="fig7">Figure 7G</xref>), with a similar time window to that observed after MCAO. Interestingly, when we induced a lesion by MCAO and performed viral overexpression of Has2 in the contralateral hemisphere, we found that Thbs4-positive astrocytes preferentially migrated to the ischemic glial scar (<xref ref-type="fig" rid="fig7">Figure 7G</xref>). This migration of Thbs4-positive astrocytes to the site of ischemic damage occurred despite no differences in HA overexpression between contralateral (Has2 infected) and ipsilateral (infarcted area) hemispheres (<xref ref-type="fig" rid="fig7">Figure 7H</xref>). These results suggest that the accumulation of HMW-HA alone is sufficient to activate and recruit Thbs4-positive astrocytes from the SVZ. However, the preferential migration to the ischemic scar indicates that brain ischemia generates a more potent biochemical signal that not only activates the SVZ but also recruits newborn astrocytes.</p></sec><sec id="s2-8"><title>Ischemia-induced gliogenesis at the SVZ correlates with local hyaluronan degradation</title><p>It is known that the niche microenvironment has a unique ECM composition (<xref ref-type="bibr" rid="bib33">Kjell et al., 2020</xref>) and that the stiffness of the niche plays a crucial role in the proliferation and differentiation of progenitor cells (<xref ref-type="bibr" rid="bib41">Long and Huttner, 2019</xref>; <xref ref-type="bibr" rid="bib49">Segel et al., 2019</xref>). After observing the close association between Thbs4-positive astrocytes and the ECM at the glial scar, we decided to study the Thbs4/HA tandem in the SVZ following MCAO (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). We did not observe any significant changes in the HA area across the entire SVZ but noted a decrease at 7 and 15 dpi in the dorsal SVZ (<xref ref-type="fig" rid="fig8">Figure 8B–D</xref>). Skeleton analysis showed fragmentation of HA exclusively in the dorsal SVZ at 7 and 15 dpi (<xref ref-type="fig" rid="fig8">Figure 8E–G</xref>), that is, earlier than the migration of these newborn astrocytes toward the lesion.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Hyaluronic acid (HA) degradation in the subventricular zone (SVZ) correlates with Thbs4 response to brain ischemia.</title><p>(<bold>A</bold>) Representative image of Thbs4 and HA (HABP) markers in the SVZ at 30 dpi. (<bold>B</bold>) Representative images of Thbs4 and HA in the sham and 15, 30 dpi SVZ. (<bold>C, D</bold>) HA levels did not change in the entire SVZ after middle cerebral artery occlusion (MCAO) (<bold>C</bold>) but decreased significantly in the dorsal SVZ (<bold>D</bold>). Thbs4 expression increased throughout the SVZ after MCAO (<bold>C</bold>), with a marked rise at 30 dpi in the dorsal SVZ (<bold>D</bold>), coinciding with HABP reduction. (<bold>E</bold>) Representative confocal (top) and skeletonized (bottom) images of HABP in the dorsal SVZ of sham, 15 and 30 dpi mice. (<bold>F</bold>) Cumulative distribution of HA skeletons showed a reduction in the length of HA cable-like structures only in the dorsal SVZ at 7 and 15 dpi. (<bold>G</bold>) The interconnectivity of the extracellular matrix decreased by 7 dpi in the dorsal SVZ, as measured by fractal dimension. (<bold>H</bold>) Experimental design for qPCR: 3–4-month-old mice were subjected to MCAO, and fresh SVZ tissue was extracted 15 and 30 days after MCAO for RT-qPCR analysis. (<bold>I</bold>) Hyaluronan degradation genes (<italic>Hyal1, Hyal2,</italic> and <italic>Hyal3</italic>) increased by 15 and 30 dpi in the SVZ, while hyaluronan synthase genes (<italic>Has1</italic> and <italic>Has2</italic>) were overexpressed later, at 30 dpi. <italic>Thbs4</italic> and <italic>Hif1a</italic> were also upregulated by 15 and 30 dpi in the SVZ. Scale bar = 100 µm (<bold>A</bold>), 20 µm (<bold>B, E</bold>). n=6 (<bold>C</bold>–<bold>E</bold> and <bold>G</bold>) and 3 (I). *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001 by Kruskal–Wallis test and Tukey post hoc test (after one-way ANOVA was significant at p&lt;0.05).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96076-fig8-v1.tif"/></fig><p>Next, we examined the expression of genes related to HA degradation (<italic>Hyal1</italic>, <italic>Hyal2,</italic> and <italic>Hyal3</italic>) and synthesis (<italic>Has1</italic> and <italic>Has2</italic>). We also analyzed <italic>Thbs4</italic> and hypoxia-inducible factor 1-alpha (<italic>Hif1a</italic>), which are known to be upregulated in the SVZ following brain ischemia (<xref ref-type="bibr" rid="bib7">Benito-Muñoz et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Liu et al., 2007</xref>). Fresh SVZ tissue was collected from sham, 15 and 30 dpi mice (<xref ref-type="fig" rid="fig8">Figure 8H</xref>). We observed an increased expression of all hyaluronidases (<italic>Hyal</italic>) at 15 dpi and slightly decreased by 30 dpi, whereas synthases (<italic>Has</italic>) showed a gradual increase from 15 to 30 dpi (<xref ref-type="fig" rid="fig8">Figure 8I</xref>). Additionally, we observed an upregulation of <italic>Thbs4</italic> and <italic>Hif1a</italic> both at 15 and 30 dpi (<xref ref-type="fig" rid="fig8">Figure 8I</xref>). These results suggest that HA degradation in the SVZ is correlated with the Thbs4 response to ischemia.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The effects of brain insult on adult neurogenesis have been extensively discussed, both in animal models and humans. However, whether these injuries can trigger the generation of newborn astrocytes from the neurogenic niches remains a topic of debate. Neural stem cells in the adult brain are a remnant of embryonic radial glia. Some researchers suggest that depletion of neurogenesis in the adult brain is a consequence of astrogliogenesis (<xref ref-type="bibr" rid="bib25">Encinas et al., 2011</xref>), while others propose astrogliogenesis is part of a neurorestorative program originating from the neurogenic niches (<xref ref-type="bibr" rid="bib10">Bonzano et al., 2018</xref>; <xref ref-type="bibr" rid="bib52">Sohn et al., 2015</xref>). Despite these differing perspectives, direct and definitive evidence of the generation of newborn astrocytes from the SVZ or the SGZ has yet to be presented, as well as the potential role of these astrocytes in aging and pathological conditions. In this study, we confirm that a strong and acute damage-associated stimulus in the brain, such as an ischemic infarct, prompts astrogliogenesis in the SVZ. Furthermore, we demonstrate that these astrocytes, which are positive for Thbs4, migrate to the glial scar and play a role in its modulation, being capable of synthesis and degradation of hyaluronan, a key component of the ECM at the scar.</p><p>Our findings align with previous studies, where cortical injury initiated by photothrombotic/ischemia was shown to trigger a substantial production of Thbs4-positive astrocytes from the SVZ, a process modulated by Notch activation (<xref ref-type="bibr" rid="bib8">Benner et al., 2013</xref>). In this work, the authors suggested a clear role for Thbs4-positive astrocytes in modulating the ischemic scar. In fact, homozygotic deletion of the Thbs4 gene led to abnormal glial scar formation and increased microvascular hemorrhage following brain ischemia. Similarly, our results demonstrate that the adult neurogenic niche at the SVZ responds early after ischemic stroke, degrading local hyaluronan plausibly to modify niche stiffness and facilitate proliferation and differentiation of NSCs. Further experiments using Thbs4-knockout models will help confirm this hypothesis.</p><p>By labeling NSC via in vivo postnatal electroporation, we provided proof of the origin and migration of newborn Thbs4-positive astrocytes from the SVZ to the ischemic scar in response to the injury. Notably, Thbs4 is expressed in the newborn astrocytes that migrate to the scar, whereas local reactive astrocytes at the site of injury express only GFAP. It is likely that SVZ-derived newborn astrocytes require Thbs4 expression to facilitate their migration to the ischemic area, as Thbs4 deletion has been shown to impair migration of SVZ-derived cells along the RMS (<xref ref-type="bibr" rid="bib31">Girard et al., 2014</xref>).</p><p>It is noteworthy that while the local, ‘GFAP-only’, reactive astrocytes at the scar are capable of forming the required ECM (<xref ref-type="bibr" rid="bib21">Cregg et al., 2014</xref>; <xref ref-type="bibr" rid="bib57">Wanner et al., 2013</xref>), we show that Thbs4-positive (Thbs4/GFAP) astrocytes are also recruited from the SVZ to modulate scar formation. Unlike local reactive astrocytes, which are hastily generated and present both at the core and periphery of the lesion, the newborn astrocytes from the SVZ arrive later to the injury. We demonstrate that these Thbs4-positive astrocytes migrate from the SVZ to the lesion and halt at the lesion border (precisely defined by Nestin staining), establishing residence at the scar but not beyond.</p><p>The molecular signals that trigger gliogenesis in the SVZ and recruit newborn astrocytes to the lesion remain unclear. We previously identified adenosine, a by-product of ATP hydrolysis, as a strong candidate, as it stimulates astrogliogenesis through A1 receptors following OGD in vitro and ischemia in vivo (<xref ref-type="bibr" rid="bib7">Benito-Muñoz et al., 2016</xref>). Here, we show that viral-mediated overproduction of HA, the primary component of the glial scar, is sufficient to activate the generation and migration of the Thbs4-positive astrocytes from the SVZ. Loss-of-function studies, using HA-depletion models or HA synthase (Has)-deficient mice, are still needed to corroborate this finding, although the inflammation associated with HA deficiency might confound interpretation. Indeed, our results also show that the ischemic infarct, with its proinflammatory (cytokines, chemokines) and proteolytic (MMPs, ROS) signals (<xref ref-type="bibr" rid="bib32">Jayaraj et al., 2019</xref>), serves as a more potent attractor than the ECM alone.</p><p>The glial response from the SVZ we propose in this study might have several functional implications. Thbs4-positive astrocytes generated from the SVZ might act as a second wave of reactivity, supporting local astrocytes in modulating ECM formation. Hyper-reactive astrocytes at the lesion border decrease over time, along with reductions in HA synthesis and CD44 activity, suggesting that the second wave of Thbs4-positive astrocytes from the SVZ could sustain high levels of HA production (<xref ref-type="bibr" rid="bib38">Lindwall et al., 2013</xref>). Thus, Thbs4-positive astrocytes may be crucial during this delayed temporal window when glial scar remodeling is essential for neurological recovery (<xref ref-type="bibr" rid="bib13">Cai et al., 2017</xref>; <xref ref-type="bibr" rid="bib24">Dzyubenko et al., 2018</xref>). However, it’s important to note that only about one-third of the astrocytes at the glial scar are derived from the SVZ. This suggests that while SVZ-derived astrocytes may be important for glial scar maintenance, local astrocytes remain the central players in this process.</p><p>Based on our observations of both HA production and internalization by Thbs4-positive astrocytes in vivo within the ischemic region and in vitro following OGD, we propose a role for these astrocytes in the modulation, and possibly maintenance, of the ECM at the scar. It is likely that ECM degradation at the scar is also carried out by professional macrophages, such as microglia, which are known to be recruited to the scar (<xref ref-type="bibr" rid="bib27">Fawcett and Asher, 1999</xref>) and have been shown to degrade ECM through phagocytosis (<xref ref-type="bibr" rid="bib44">Nguyen et al., 2020</xref>; <xref ref-type="bibr" rid="bib53">Soria et al., 2020</xref>). Understanding which cells within the scar environment participate in its modulation, particularly its degradation, holds highly therapeutic value for promoting regeneration (<xref ref-type="bibr" rid="bib24">Dzyubenko et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Silver and Miller, 2004</xref>). Here, we shed light on the unknown role of SVZ-derived astrocytes activated by ischemic brain injury and propose them as critical players in tissue regeneration after brain ischemia.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals</title><p>Male and female wild-type C57BL/6J mice and Ai14-Rosa26-CAG-tdTomato<sup>flx/flx</sup> transgenic mice bred at the animal facility of UPV/EHU were used for in vivo experiments. Sprague–Dawley rat pups from P4 to P7 were used for in vitro experiments. Animals were maintained under standard laboratory conditions with food and water ad libitum. All animals were handled in accordance with the European Communities Council Directive (2010/63/EU) and approved by the Ethics Committee of the University of the Basque Country (UPV/EHU) under license CEEA/340/2013.</p></sec><sec id="s4-2"><title>Transient MCAO</title><p>Brain ischemia was induced in 3–4-month-old C57BL/6 mice (approximately 25 g) by occluding 60 minutes of the lenticulo-striate arteries with a 10 mm length of silicone-coated 6-0 monofilament nylon suture (602223PK10, Doccol Corporation) using a modification of the protocol described by <xref ref-type="bibr" rid="bib30">Gelderblom et al., 2009</xref>. Artery occlusion generated a specific lesion in the cortex and striatum that was evaluated at different times after the MCAO (7, 15, 30, or 60 days after occlusion). Ischemic damage was evaluated in the ipsilateral hemisphere by Cresyl violet staining, Nestin immunofluorescence, or hyaluronan staining. Sham animals, in which arteries were visualized but not disturbed, were used as an experimental control. Both experimental groups, sham and ischemic, were anesthetized with a mix of isoflurane and oxygen (induction of anesthesia with 4% isoflurane and maintenance for surgery at 1.5% isoflurane) and maintained under analgesia with buprenorphine 24 hours after ischemia (0.03 mg/kg body weight i.p. every 12 hours). Animal wellness was evaluated daily, controlling the body weight and the motor deficit of the animal by means of neurological scores and pole test. Motor deficit was assessed in each animal 1 hours after MCAO and later every 24 hours. Animals without neurological deficits were excluded from the study.</p></sec><sec id="s4-3"><title>5-bromo-2'-deoxyuridine (BrdU) protocol</title><p>The total pool of proliferating cells was labeled with three injections of 50 mg/kg 5-bromo-2'-deoxyuridine (BrdU) the day before MCAO protocol. Animals were sacrificed the day after MCAO to analyze acute SVZ proliferation. Chronic BrdU protocol was performed for quiescent NSC identification (<xref ref-type="bibr" rid="bib20">Codega et al., 2014</xref>). Briefly, 1% of BrdU was administered in the drinking water for 14 days. On day 15, BrdU was removed and animals were subjected to the MCAO protocol. Mice were sacrificed and perfused at 3, 7, 15, and 30 days after MCAO, although only animals with a temporal window of 30 days between MCAO and perfusion were used for statistical analysis. Activated cells were labeled by i.p. injection of 50 mg/kg 5-iodo-2′-deoxyuridine (IdU) 24 hours before euthanasia.</p></sec><sec id="s4-4"><title>Electroporation</title><p>Ai14-Rosa26-CAG-tdTomato<sup>flx/flx</sup> transgenic mice and pCAGGS-CRE plasmid were kindly provided for Prof. Harold Cremer and Marie-Catherine Tiveron from the Institut de Biologie du Développement de Marseille (IBDM). Postnatal electroporation was performed as described previously (<xref ref-type="bibr" rid="bib45">Platel et al., 2019</xref>). Mice pups from P0-P2 were anesthetized by hypothermia. pCAGGS-CRE plasmid was used at a final concentration of 2.5 µg/ul and 2 µl was injected in the lateral ventricle by expiratory pressure using a glass micropipette. Following injection, pup brains were placed between electrodes targeted at the dorsal SVZ and subjected to five 95 V electrical pulses (50 ms, 950 ms intervals). BTX ECM399 (Thermo Fisher Scientific) electroporator was used with 7 mm tweezer electrodes. Electroporated pups were reanimated at 37°C before returning to the mother.</p><p>In order to analyze the Thbs4-positive cells in the SVZ, we subcloned the eGFP gene (from a pCMV-eGFP N1) into a PGL3-basic backbone containing mouse Thbs4 promoter, kindly provided by Stenina-Adognravi lab (<xref ref-type="bibr" rid="bib43">Muppala et al., 2017</xref>). pThbs4-GFP was also electroporated in P0-P2 mice and euthanized 1 day post-electroporation to corroborate Thbs4 expression in the SVZ at postnatal stages.</p></sec><sec id="s4-5"><title>AAV vector production</title><p>AAV2/9-CAG-Has2-3xFlag vector was produced by polyethylenimine (PEI)-mediated triple transfection of low-passage HEK-293 T/17 cells (ATCC; Cat# CRL-11268). The respective AAV expression plasmid expression plasmid pNMRHas2_N1 (provided by Dr. Vera Gorbunova) was cotransfected with the adeno helper pAd Delta F6 plasmid (Penn Vector Core, Cat# PL-F-PVADF6) and AAV Rep Cap pAAV2/9 plasmid (Penn Vector Core, Cat# PL-TPV008). AAV vector was purified as previously described (<xref ref-type="bibr" rid="bib11">Bourdenx et al., 2015</xref>). Cells are harvested 72 hours post-transfection, resuspended in lysis buffer (150 mM NaCl, 50 mM Tris–HCl pH 8.5), and lysed by three freeze–thaw cycles (37°C/–80°C). The cell lysate is treated with 150 units/ml Benzonase (Sigma, St Louis, MO) for 1 hours at 37°C, and the crude lysate is clarified by centrifugation. Vectors are purified by iodixanol step gradient centrifugation and concentrated and buffer-exchanged into Lactated Ringer’s solution (Baxter, Deerfield, IL) using vivaspin20 100 kDa cut-off concentrator (Sartorius Stedim, Goettingen, Germany). Titrations were performed at the transcriptome core facility (Neurocentre Magendie, INSERM U862, Bordeaux, France). The genome-containing particle (gcp) titer was determined at a concentration of 1.10<sup>13</sup> gcp/ml by quantitative real-time PCR using the Light Cycler 480 SYBR green master mix (Roche, Cat# 04887352001) with primers specific for the AAV2 ITRs (fwd 50-<named-content content-type="sequence">GGAACCCCTAGTGATG GAGTT</named-content>-3’; rev 50-<named-content content-type="sequence">CGGCCTCAGTGAGCGA</named-content>-30) on a Light Cycler 480 instrument. The purity assessment of vector stocks was estimated by loading 10 μl of vector stock on 10% SDS acrylamide gels; total proteins were visualized using the Krypton Infrared Protein Stain according to the manufacturer’s instructions (Life Technologies).</p></sec><sec id="s4-6"><title>In vivo AAV-HAS2 injections</title><p>Mice were anesthetized with isoflurane and fixed to a stereotaxic frame connected with a gas mask. We injected 1 µl of adeno-associated virus (AAV2/9) CAG-Has2-3xFlag (1 × 10<sup>13</sup> gc/µl) in the contralateral striatum (AP:+1.0; ML: –1.8; DV: –3.2) to simulate scar tissue hyaluronan. After 2 weeks, the ischemic group was subjected to the MCAO model in the ipsilateral hemisphere and perfused 30 days later. Only slices with representative lesions in both hemispheres were used for image and statistical analysis.</p></sec><sec id="s4-7"><title>Immunofluorescence</title><p>Mice were anesthetized with an intraperitoneal injection of pentobarbital (100 mg/kg). Brain tissues were fixed by intracardiac perfusion using 4% paraformaldehyde. Fixed brains were sliced at 40 μm of thickness using the Leica VT1200S vibratome (Leica Microsystems) and subjected to immunofluorescence. For standard immunofluorescence protocol, tissue slices were permeabilized with 0.1% Triton and non-specific epitopes blocked with 1% bovine serum albumin (BSA) and 10% donkey serum in PBS. Primary antibodies were incubated at different concentrations (see <xref ref-type="table" rid="table1">Table 1</xref> for specification) overnight at 4°C and then washed three times with 0.1% Triton in PBS. Secondary conjugated antibodies were incubated for 1 hour at room temperature. After three washes with 0.1% Triton in PBS, cells were stained for 10 minutes with DAPI and further washed with PBS. Finally, coverslips were mounted with Fluoromount (SouthernBiotech) and analyzed by fluorescence using the confocal microscope Leica TCS SP8. For HA labeling, endogenous biotins were pre-blocked using Streptavidin/Biotin blocking solution (Vector Labs, #SP-2002) following the manufacturer’s instructions and further blocked with PBS 1X0.1% Saponin 1% BSA for 1 hour at room temperature. Primary antibodies and biotinylated Hyaluronic Acid Binding Protein (HABP, #385911 Millipore) were incubated for 72 hours at 4°C or 24 hours at room temperature. After three washes with PBS, 1X0.1% Saponin, secondary antibody, and DAPI diluted in the same blocking buffer were incubated for 1 hour at room temperature. Slices were mounted with Mowiol (Millipore #475904) in superfrost slides (Thermo Fisher Scientific) and #1.5 coverslips.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Primary antibodies used for in vivo immunofluorescence protocol.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Antibody</th><th align="left" valign="top">Host</th><th align="left" valign="top">Isotope</th><th align="left" valign="top">Dilution</th><th align="left" valign="top">Reference</th><th align="left" valign="top">Company</th></tr></thead><tbody><tr><td align="left" valign="top">Thbs4</td><td align="left" valign="top">Mouse</td><td align="left" valign="top">Monoclonal IgM kappa light chain</td><td align="char" char="." valign="top">1/400</td><td align="left" valign="top">Sc-390734</td><td align="left" valign="top">Santa Cruz Biotechnology, USA.</td></tr><tr><td align="left" valign="top">Thbs4</td><td align="left" valign="top">Goat</td><td align="left" valign="top">Polyclonal IgG</td><td align="char" char="." valign="top">1/200</td><td align="left" valign="top">AF2390</td><td align="left" valign="top">R&amp;B Systems, USA</td></tr><tr><td align="left" valign="top">S100β</td><td align="left" valign="top">Rabbit</td><td align="left" valign="top">Polyclonal</td><td align="char" char="." valign="top">1/400</td><td align="left" valign="top">Z0311</td><td align="left" valign="top">Dako, Agilent Technologies, Inc</td></tr><tr><td align="left" valign="top">S100β</td><td align="left" valign="top">Mouse</td><td align="left" valign="top">Monoclonal IgG2a</td><td align="char" char="." valign="top">1/1000</td><td align="left" valign="top">MA5-12969</td><td align="left" valign="top">Invitrogen, Spain</td></tr><tr><td align="left" valign="top">GFAP</td><td align="left" valign="top">Mouse</td><td align="left" valign="top">Monoclonal IgG1</td><td align="char" char="." valign="top">1/1000</td><td align="left" valign="top">MAB3402</td><td align="left" valign="top">Sigma, Spain</td></tr><tr><td align="left" valign="top">GFAP</td><td align="left" valign="top">Rabbit</td><td align="left" valign="top">Polyclonal</td><td align="char" char="." valign="top">1/4000</td><td align="left" valign="top">Z0334</td><td align="left" valign="top">Dako, Agilent Technologies, Inc</td></tr><tr><td align="left" valign="top">βIII tubulin</td><td align="left" valign="top">Rabbit</td><td align="left" valign="top">Polyclonal</td><td align="char" char="." valign="top">1/400</td><td align="left" valign="top">ab18207</td><td align="left" valign="top">Abcam, UK</td></tr><tr><td align="left" valign="top">NeuN</td><td align="left" valign="top">Mouse</td><td align="left" valign="top">Monoclonal IgG1</td><td align="char" char="." valign="top">1/1000</td><td align="left" valign="top">MAB377</td><td align="left" valign="top">Millipore, Germany</td></tr><tr><td align="left" valign="top">DCX</td><td align="left" valign="top">Rabbit</td><td align="left" valign="top">Polyclonal IgG</td><td align="char" char="." valign="top">1/500</td><td align="left" valign="top">ab18723</td><td align="left" valign="top">Abcam, UK</td></tr><tr><td align="left" valign="top">Nestin</td><td align="left" valign="top">Chicken</td><td align="left" valign="top">Polyclonal IgY</td><td align="char" char="." valign="top">1/1000</td><td align="left" valign="top">NES</td><td align="left" valign="top">Aves Lab, EEUU</td></tr><tr><td align="left" valign="top">Prominin 1</td><td align="left" valign="top">Rat</td><td align="left" valign="top">Monoclonal IgG1 kappa</td><td align="char" char="." valign="top">1/300</td><td align="char" char="hyphen" valign="top">14-1331-82</td><td align="left" valign="top">Invitrogen, Spain</td></tr><tr><td align="left" valign="top">EGFR</td><td align="left" valign="top">Mouse</td><td align="left" valign="top">Monoclonal</td><td align="char" char="." valign="top">1/400</td><td align="left" valign="top">SAB4200809</td><td align="left" valign="top">Abcam, UK</td></tr><tr><td align="left" valign="top">BrdU</td><td align="left" valign="top">Rat</td><td align="left" valign="top">Monoclonal</td><td align="char" char="." valign="top">1/400</td><td align="left" valign="top">MCA2060</td><td align="left" valign="top">Bio-Rad, USA</td></tr><tr><td align="left" valign="top">BrdU</td><td align="left" valign="top">Mouse</td><td align="left" valign="top">Monoclonal IgG1, kappa</td><td align="char" char="." valign="top">1/500</td><td align="char" char="ndash" valign="top">03-3900</td><td align="left" valign="top">Invitrogen, Spain</td></tr><tr><td align="left" valign="top">IdU</td><td align="left" valign="top">Mouse</td><td align="left" valign="top">Monoclonal IgG2b</td><td align="char" char="." valign="top">1/100</td><td align="left" valign="top">MA5-24879</td><td align="left" valign="top">Invitrogen, Spain</td></tr><tr><td align="left" valign="top">Ki67</td><td align="left" valign="top">Rabbit</td><td align="left" valign="top">Polyclonal IgG</td><td align="char" char="." valign="top">1/400</td><td align="left" valign="top">Ab15580</td><td align="left" valign="top">Abcam, UK</td></tr><tr><td align="left" valign="top">Cleaved-Caspase 3</td><td align="left" valign="top">Rabbit</td><td align="left" valign="top">Monoclonal IgG</td><td align="char" char="." valign="top">1/300</td><td align="left" valign="top">#9664</td><td align="left" valign="top">Cell Signaling, Germany</td></tr><tr><td align="left" valign="top">CD44</td><td align="left" valign="top">Rat</td><td align="left" valign="top">Monoclonal IgG2b</td><td align="char" char="." valign="top">1/500</td><td align="left" valign="top">MA517875</td><td align="left" valign="top">Invitrogen, Spain</td></tr><tr><td align="left" valign="top">FLAG</td><td align="left" valign="top">Mouse</td><td align="left" valign="top">Monoclonal IgG1</td><td align="char" char="." valign="top">1/500</td><td align="left" valign="top">F1804</td><td align="left" valign="top">Sigma, Spain</td></tr><tr><td align="left" valign="top">Olig2</td><td align="left" valign="top">Mouse</td><td align="left" valign="top">Monoclonal IgG2aκ</td><td align="char" char="." valign="top">1/1000</td><td align="left" valign="top">MABN50</td><td align="left" valign="top">Millipore, Germany</td></tr></tbody></table></table-wrap></sec><sec id="s4-8"><title>Imaging and image analysis</title><p>Confocal images were acquired in a Leica TCS SP8 with ×20 (0.8 NA) and ×63 objectives (1.4 NA). Images were taken with a pixel size of 90 nm. Widefield imaging was performed in a Zeiss AxioVision fluorescence microscope and a 3DHISTECH panoramic MIDI II digital slide scanner. Settings were adjusted for each individual experiment and kept for all conditions. Image processing was performed using FIJI (<xref ref-type="bibr" rid="bib48">Schindelin et al., 2012</xref>), CaseViewer, and Hyugens (SVI, The Netherlands) software. For Thbs4, Nestin, and DCX immunofluorescence, wholemount SVZ preparations and AAV-HAS2 analysis, tile-scan was done using the navigator plug-in in the LasX software. For Nestin immunofluorescence, images were deconvoluted using the Hyugens software.</p><p>SVZ images were reconstructed using the tile-scan tool (LasX software, Leica). SVZ ROI was delimited manually and expression of each marker was measured in the SVZ ROI. Quantification of all markers was done manually, except for HABP quantification, which was done with custom FIJI scripts for in vitro (<ext-link ext-link-type="uri" xlink:href="https://github.com/MariArdaya/Hyaluronan_v2">https://github.com/MariArdaya/Hyaluronan_v2</ext-link>, copy archived at <xref ref-type="bibr" rid="bib3">Ardaya, 2025</xref>) and in vivo analysis (<ext-link ext-link-type="uri" xlink:href="https://github.com/SoriaFN/Tools">https://github.com/SoriaFN/Tools</ext-link>, copy archived at <xref ref-type="bibr" rid="bib54">Soria, 2025</xref>). The HABP signal was segmented with an automatic threshold and colocalized with other markers such as CD44. This, combined with cell segmentation, based on the Thbs4 mask, allowed for quantification of HABP area and number of spots inside cells, outside cells, or at the membrane (with a band ROI of 1 μm). The Analyze Skeleton and Fractal count plugins were used on the skeletonized segmented HABP to quantify the longest shortest path and the fractal dimension, respectively, to reveal the length and interconnectivity of the matrix network (<xref ref-type="bibr" rid="bib14">Casey et al., 2024</xref>; <xref ref-type="bibr" rid="bib53">Soria et al., 2020</xref>).</p></sec><sec id="s4-9"><title>Western blot</title><p>The SVZ was freshly dissected on ice and minced using a micro grinder. Total protein was extracted after tissue lysis with RIPA buffer (Thermo Fisher Scientific #89900) and Protease and Phosphatase Inhibitor Cocktail 100X (Thermo Fisher Scientific). Samples were lysed in ice for 10 minutes and sonicated using an Ultrasonic Processor (Hielscher Ultrasound Technology). Sonicated tissues were centrifuged at 1200 rpm for 10 minutes and 4°C to remove insoluble fragments. Protein concentration was measured by chemiluminescence using RC DC Protein Assay (Bio-Rad). Then, 40 µg of protein samples were denatured in reducing loading buffer containing β-mercaptoethanol (M3148, Sigma) and 0.0002% bromophenol blue at 95°C for 5 minutes and separated in pre-casted 12% or 7.5% Tris-Glycine polyacrylamide gel using the Criterion cell system (Bio-Rad). Electrophoresis was conducted at 80 V in a Tris-Glycine buffer (25 mM Tris, 192 mM glycine, 0.1% SDS in dH<sub>2</sub>O, pH 8.3). After complete separation, proteins were transferred to a nitrocellulose membrane (Bio-Rad) using Trans-Blot Turbo Transfer System (Bio-Rad). Nitrocellulose membranes were incubated in blocking solution (Tris-buffer solution, 0.1% Tween-20 and 5% BSA) for 1 hour at room temperature. Primary antibodies were incubated overnight at 4°C. Fluorescent or horseradish peroxidase-conjugated secondary antibodies were incubated in blocking buffer for 1 hour at room temperature. Immunodetection was performed using chemiluminescence or fluorescence on a Chemidoc MP (Bio-Rad) and the intensity of the bands was quantified using ImageLab (Bio-Rad) software corrected by Gaussian curves.</p></sec><sec id="s4-10"><title>qRT-PCR</title><p>Fresh SVZ tissue from ipsilateral hemisphere was isolated as previously described from sham, 15 and 30 days after MCAO animals to analyze the expression of several genes (<xref ref-type="table" rid="table2">Table 2</xref>). After mechanical trituration, RNA was extracted from the tissue following the manufacturer’s protocol (NZYTECH Total RNA Isolation kit protocol, NZYTECH, MB13402). RNA concentration was measured by spectrophotometry using the Nanodrop 2000c spectrophotometer (Thermo Scientific, USA). Real-time polymerase chain reaction (RT-PCR) from 10 ng of RNA was performed using the One-step NZYTECH RT-qPCR Green kit according to the manufacturer’s protocol (NZYTECH, MB34302). RT-PCR was normalized using the housekeeping genes hypoxanthine phosphoribosyl-transferase 1 (HPRT1, QIAGEN QuantiTect Primer Assay, Barcelona, Spain). Specificity of each amplification was confirmed by melting curve analysis. PCR reactions were performed in a CFX96 Detection System (Bio-Rad, Madrid, Spain). Semi-quantification was performed using the 2-ΔΔCt algorithm. Unsupervised hierarchical distance matrix and distance matrix map was developed using Orange3 software (Python v3.0).</p></sec><sec id="s4-11"><title>Neural stem cell culture</title><p>Neurosphere cultures were prepared from 4 to 7-day-old Sprague–Dawley rat pups as previously described (<xref ref-type="bibr" rid="bib16">Cavaliere et al., 2012</xref>). Briefly, the SVZ was isolated and minced with a McIllwain tissue chopper (Campden Instruments). SVZs from 2 to 3 brains were digested for 7 minutes at 37°C in 5 ml of trypsin/EDTA (Sigma). Digestion was stopped by adding an equal volume of trypsin inhibitor (Sigma) and 0.01% DNAse I (Sigma). The cell suspension was centrifuged and the pellet mechanically dissociated in NeuroCult medium (StemCell, France). Cells were seeded in proliferation medium: NeuroCult with 10% NSC factors (StemCell), penicillin/streptomycin mix, 20 ng/ml EGF (Promega), 10 ng/ml bFGF (Promega), and cultured in suspension for 7 days at 37°C and 5% CO<sub>2</sub>.</p><p>After 7 days of proliferation, neurospheres were enzymatically dissociated with Accutase (Sigma) and seeded in poly-L-ornithine-coated (Gibco) 0.17 mm glass coverslips at 100.000 cells/well. Cells were differentiated into astrocytes in serum-free medium. The following day, differentiation medium was replaced by oxygen and glucose deprivation (OGD) medium (130 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl<sub>2</sub>, 26 mM NaHCO<sub>3</sub>, 0.8 mM MgCl<sub>2</sub>, 1.18 mM NaH<sub>2</sub>PO<sub>4</sub>, 10 mM sucrose, pH 7.2) previously saturated with N<sub>2</sub>. Cells were subjected to OGD for 60 minutes in 3% O<sub>2</sub>. After OGD, cells were returned to standard medium, differentiated for 7–10 days and fixed with 4% paraformaldehyde. In some experiments, hyaluronidase (OmniPur Hyaluronidase Sigma, HX0514-1) was added to the medium to remove extracellular HA. To measure metalloproteases activity in culture medium following OGD, we used the MMP Activity Assay Kit (Abcam), which employs GFP as an MMP activity reporter and DAPI as a normalization dye.</p></sec><sec id="s4-12"><title>Statistical analysis</title><p>Statistical analysis was done using GraphPad Prism software (version 8.0; GraphPad software). Data are presented as mean ± SEM unless specified otherwise. Statistical analysis was performed using unpaired Student’s <italic>t</italic>-test for independent conditions and paired Student’s <italic>t</italic>-test for dependent conditions. In addition, one-way and two-way ANOVA were also performed to compare more than two groups among them. Tukey and Dunnett post hoc tests were used. For HABP skeleton analysis, Kruskal–Wallis analysis was performed to compare cumulative frequency curves in more than two groups. p-Value was considered significant at p&lt;0.05. Sample number (n), p-values, and statistical test are indicated in figure legends.</p></sec><sec id="s4-13"><title>Materials availability</title><p>The AAV-Has2-NMR vector is available from the corresponding authors upon reasonable request.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Primer sequences for qPCR.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Name</th><th align="left" valign="top">Sequence</th></tr></thead><tbody><tr><td align="left" valign="top">Hyal1_FW</td><td align="left" valign="top"><named-content content-type="sequence">GTGCCAAGCCCTATGCTAATAAG</named-content></td></tr><tr><td align="left" valign="top">Hyal1_REV</td><td align="left" valign="top"><named-content content-type="sequence">GCATGTCCATTGCAAAGACTGA</named-content></td></tr><tr><td align="left" valign="top">Hyal2_FW</td><td align="left" valign="top"><named-content content-type="sequence">GTCCCACATACACCCGAGGA</named-content></td></tr><tr><td align="left" valign="top">Hyal2_REV</td><td align="left" valign="top"><named-content content-type="sequence">GGCACTCTCACCGATGGTAGA</named-content></td></tr><tr><td align="left" valign="top">Hyal3_Ffw</td><td align="left" valign="top"><named-content content-type="sequence">GGACGACCTGATGCAGACTATTG</named-content></td></tr><tr><td align="left" valign="top">Hyal3_REV</td><td align="left" valign="top"><named-content content-type="sequence">GGTCCCCCCAGAGTACCACT</named-content></td></tr><tr><td align="left" valign="top">Has1_FW</td><td align="left" valign="top"><named-content content-type="sequence">AGGGCTCTTAAAGGAGGAGTCC</named-content></td></tr><tr><td align="left" valign="top">Has1_REV</td><td align="left" valign="top"><named-content content-type="sequence">AGAAGGTAAACTGAGTCCCCAGAA</named-content></td></tr><tr><td align="left" valign="top">Has2_FW</td><td align="left" valign="top"><named-content content-type="sequence">CAAAGAGGTTCGTTCAAGTTCTGA</named-content></td></tr><tr><td align="left" valign="top">Has2_REV</td><td align="left" valign="top"><named-content content-type="sequence">TGTGTTTGTTTCCCACTAGCTCTC</named-content></td></tr><tr><td align="left" valign="top">Hif1a_FW</td><td align="left" valign="top"><named-content content-type="sequence">CATAAAGTCTGCAACATGGAAGGT</named-content></td></tr><tr><td align="left" valign="top">Hif1a_REV</td><td align="left" valign="top"><named-content content-type="sequence">ATTTGATGGGTGAGGAATGGGTT</named-content></td></tr><tr><td align="left" valign="top">HPRT1_FW</td><td align="left" valign="top"><named-content content-type="sequence">TGATAGATCCATTCCTATGACTGTAGA</named-content></td></tr><tr><td align="left" valign="top">HPRT1_REV</td><td align="left" valign="top"><named-content content-type="sequence">AAGACATTCTTTCCAGTTAAAGTTGAG</named-content></td></tr></tbody></table></table-wrap></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Investigation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Resources, Supervision, Methodology</p></fn><fn fn-type="con" id="con3"><p>Resources, Supervision, Methodology</p></fn><fn fn-type="con" id="con4"><p>Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources, Supervision</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources</p></fn><fn fn-type="con" id="con7"><p>Supervision</p></fn><fn fn-type="con" id="con8"><p>Funding acquisition</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Software, Supervision, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animals were maintained under standard laboratory conditions with food and water ad libitum. All animals were handled in accordance with the European Communities Council Directive (2010/63/EU) and approved by the Ethics Committee of the University of the Basque Country (EHU) under license CEEA/340/2013.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-96076-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Contains source data for all figures.</title></caption><media xlink:href="elife-96076-data1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Juan Carlos Chara, Zara Martínez-Paez, and Laura Escobar for their invaluable technical support. We thank Laura Simon for proofreading the manuscript, and Mónica Benito-Muñoz, and Sol Beccari for training in MCAO in mice. We also thank Vera Gorbunova (University of Rochester, USA) for providing the cDNA of HAS2 from the naked mole rat. We thank Marie-Laure Thiolat and Dr. Nathalie Dutheil for AAV production. This study received financial support from the French government in the framework of the University of Bordeaux’s IdEx 'Investments for the Future' program/GPR BRAIN_2030 (BD). FC acknowledges funding from BIOEF (BIO21/COV/012), Eukampus, Plan Complementario en Salud (PRTR-C17.I1) and the Basque Government. FNS was funded by the Spanish Research Agency (IJCI-2017-32114, PID2020-115896RJ-I00, and RYC2021-032602-I co-funded by NextGeneration EU/PRTR). CM acknowledges funding from the Basque Government (IT1203-19) and CIBERNED. AM acknowledges grant PCI2022-134986-2 funded by Spanish Research Agency /10.13039/501100011033 and European Union NextGenerationEU/PRTR. This work was also supported by the Fédération pour la Recherche sur le Cerveau, the Agence National pour la Recherche Grant ANR- 17-CE16-0025-02, ANR-21-CE16-0034-01, ANR-21-CE13-0003, and the Fondation pour la Recherche Médicale, EQU201903007806 grants to HC. MA was supported by a PhD fellowship from the Basque Government.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>KL</given-names></name><name><surname>Gallo</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The diversity and disparity of the glial scar</article-title><source>Nature Neuroscience</source><volume>21</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1038/s41593-017-0033-9</pub-id><pub-id pub-id-type="pmid">29269757</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>MA</given-names></name><name><surname>Burda</surname><given-names>JE</given-names></name><name><surname>Ren</surname><given-names>Y</given-names></name><name><surname>Ao</surname><given-names>Y</given-names></name><name><surname>O’Shea</surname><given-names>TM</given-names></name><name><surname>Kawaguchi</surname><given-names>R</given-names></name><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Khakh</surname><given-names>BS</given-names></name><name><surname>Deming</surname><given-names>TJ</given-names></name><name><surname>Sofroniew</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Astrocyte scar formation aids central nervous system axon regeneration</article-title><source>Nature</source><volume>532</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1038/nature17623</pub-id><pub-id pub-id-type="pmid">27027288</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Ardaya</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>Hyaluronan_v2</data-title><version designator="swh:1:rev:7a4a18198b65c16de6cbf193a16fe1abae60cfee">swh:1:rev:7a4a18198b65c16de6cbf193a16fe1abae60cfee</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:6486775a7323f9c7bb63d2bf0ae86a2762eb754c;origin=https://github.com/MariArdaya/Hyaluronan_v2;visit=swh:1:snp:8ac5d88a99c714b85a27e0f72cd9d144f0259580;anchor=swh:1:rev:7a4a18198b65c16de6cbf193a16fe1abae60cfee">https://archive.softwareheritage.org/swh:1:dir:6486775a7323f9c7bb63d2bf0ae86a2762eb754c;origin=https://github.com/MariArdaya/Hyaluronan_v2;visit=swh:1:snp:8ac5d88a99c714b85a27e0f72cd9d144f0259580;anchor=swh:1:rev:7a4a18198b65c16de6cbf193a16fe1abae60cfee</ext-link></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arvidsson</surname><given-names>A</given-names></name><name><surname>Collin</surname><given-names>T</given-names></name><name><surname>Kirik</surname><given-names>D</given-names></name><name><surname>Kokaia</surname><given-names>Z</given-names></name><name><surname>Lindvall</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Neuronal replacement from endogenous precursors in the adult brain after stroke</article-title><source>Nature Medicine</source><volume>8</volume><fpage>963</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1038/nm747</pub-id><pub-id pub-id-type="pmid">12161747</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basak</surname><given-names>O</given-names></name><name><surname>Krieger</surname><given-names>TG</given-names></name><name><surname>Muraro</surname><given-names>MJ</given-names></name><name><surname>Wiebrands</surname><given-names>K</given-names></name><name><surname>Stange</surname><given-names>DE</given-names></name><name><surname>Frias-Aldeguer</surname><given-names>J</given-names></name><name><surname>Rivron</surname><given-names>NC</given-names></name><name><surname>van de Wetering</surname><given-names>M</given-names></name><name><surname>van Es</surname><given-names>JH</given-names></name><name><surname>van Oudenaarden</surname><given-names>A</given-names></name><name><surname>Simons</surname><given-names>BD</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Troy+ brain stem cells cycle through quiescence and regulate their number by sensing niche occupancy</article-title><source>PNAS</source><volume>115</volume><fpage>E610</fpage><lpage>E619</lpage><pub-id pub-id-type="doi">10.1073/pnas.1715911114</pub-id><pub-id pub-id-type="pmid">29311336</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckervordersandforth</surname><given-names>R</given-names></name><name><surname>Tripathi</surname><given-names>P</given-names></name><name><surname>Ninkovic</surname><given-names>J</given-names></name><name><surname>Bayam</surname><given-names>E</given-names></name><name><surname>Lepier</surname><given-names>A</given-names></name><name><surname>Stempfhuber</surname><given-names>B</given-names></name><name><surname>Kirchhoff</surname><given-names>F</given-names></name><name><surname>Hirrlinger</surname><given-names>J</given-names></name><name><surname>Haslinger</surname><given-names>A</given-names></name><name><surname>Lie</surname><given-names>DC</given-names></name><name><surname>Beckers</surname><given-names>J</given-names></name><name><surname>Yoder</surname><given-names>B</given-names></name><name><surname>Irmler</surname><given-names>M</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>In vivo fate mapping and expression analysis reveals molecular hallmarks of prospectively isolated adult neural stem cells</article-title><source>Cell Stem Cell</source><volume>7</volume><fpage>744</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2010.11.017</pub-id><pub-id pub-id-type="pmid">21112568</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benito-Muñoz</surname><given-names>M</given-names></name><name><surname>Matute</surname><given-names>C</given-names></name><name><surname>Cavaliere</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Adenosine A1 receptor inhibits postnatal neurogenesis and sustains astrogliogenesis from the subventricular zone</article-title><source>Glia</source><volume>64</volume><fpage>1465</fpage><lpage>1478</lpage><pub-id pub-id-type="doi">10.1002/glia.23010</pub-id><pub-id pub-id-type="pmid">27301342</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benner</surname><given-names>EJ</given-names></name><name><surname>Luciano</surname><given-names>D</given-names></name><name><surname>Jo</surname><given-names>R</given-names></name><name><surname>Abdi</surname><given-names>K</given-names></name><name><surname>Paez-Gonzalez</surname><given-names>P</given-names></name><name><surname>Sheng</surname><given-names>H</given-names></name><name><surname>Warner</surname><given-names>DS</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Eroglu</surname><given-names>C</given-names></name><name><surname>Kuo</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Protective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4</article-title><source>Nature</source><volume>497</volume><fpage>369</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1038/nature12069</pub-id><pub-id pub-id-type="pmid">23615612</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>AM</given-names></name><name><surname>Ming</surname><given-names>GL</given-names></name><name><surname>Song</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Adult mammalian neural stem cells and neurogenesis: five decades later</article-title><source>Cell Stem Cell</source><volume>17</volume><fpage>385</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2015.09.003</pub-id><pub-id pub-id-type="pmid">26431181</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonzano</surname><given-names>S</given-names></name><name><surname>Crisci</surname><given-names>I</given-names></name><name><surname>Podlesny-Drabiniok</surname><given-names>A</given-names></name><name><surname>Rolando</surname><given-names>C</given-names></name><name><surname>Krezel</surname><given-names>W</given-names></name><name><surname>Studer</surname><given-names>M</given-names></name><name><surname>De Marchis</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neuron-astroglia cell fate decision in the adult mouse hippocampal neurogenic niche is cell-intrinsically controlled by COUP-TFI in vivo</article-title><source>Cell Reports</source><volume>24</volume><fpage>329</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.06.044</pub-id><pub-id pub-id-type="pmid">29996095</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourdenx</surname><given-names>M</given-names></name><name><surname>Dovero</surname><given-names>S</given-names></name><name><surname>Engeln</surname><given-names>M</given-names></name><name><surname>Bido</surname><given-names>S</given-names></name><name><surname>Bastide</surname><given-names>MF</given-names></name><name><surname>Dutheil</surname><given-names>N</given-names></name><name><surname>Vollenweider</surname><given-names>I</given-names></name><name><surname>Baud</surname><given-names>L</given-names></name><name><surname>Piron</surname><given-names>C</given-names></name><name><surname>Grouthier</surname><given-names>V</given-names></name><name><surname>Boraud</surname><given-names>T</given-names></name><name><surname>Porras</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Baekelandt</surname><given-names>V</given-names></name><name><surname>Scheller</surname><given-names>D</given-names></name><name><surname>Michel</surname><given-names>A</given-names></name><name><surname>Fernagut</surname><given-names>P-O</given-names></name><name><surname>Georges</surname><given-names>F</given-names></name><name><surname>Courtine</surname><given-names>G</given-names></name><name><surname>Bezard</surname><given-names>E</given-names></name><name><surname>Dehay</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression</article-title><source>Acta Neuropathologica Communications</source><volume>3</volume><elocation-id>46</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-015-0222-2</pub-id><pub-id pub-id-type="pmid">26205255</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bush</surname><given-names>TG</given-names></name><name><surname>Puvanachandra</surname><given-names>N</given-names></name><name><surname>Horner</surname><given-names>CH</given-names></name><name><surname>Polito</surname><given-names>A</given-names></name><name><surname>Ostenfeld</surname><given-names>T</given-names></name><name><surname>Svendsen</surname><given-names>CN</given-names></name><name><surname>Mucke</surname><given-names>L</given-names></name><name><surname>Johnson</surname><given-names>MH</given-names></name><name><surname>Sofroniew</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice</article-title><source>Neuron</source><volume>23</volume><fpage>297</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80781-3</pub-id><pub-id pub-id-type="pmid">10399936</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Mu</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>GY</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hypoxia response element-regulated MMP-9 promotes neurological recovery via glial scar degradation and angiogenesis in delayed stroke</article-title><source>Molecular Therapy</source><volume>25</volume><fpage>1448</fpage><lpage>1459</lpage><pub-id pub-id-type="doi">10.1016/j.ymthe.2017.03.020</pub-id><pub-id pub-id-type="pmid">28396199</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casey</surname><given-names>DT</given-names></name><name><surname>Lahue</surname><given-names>KG</given-names></name><name><surname>Mori</surname><given-names>V</given-names></name><name><surname>Herrmann</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>JK</given-names></name><name><surname>Suki</surname><given-names>B</given-names></name><name><surname>Janssen-Heininger</surname><given-names>YMW</given-names></name><name><surname>Bates</surname><given-names>JHT</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Local fractal dimension of collagen detects increased spatial complexity in fibrosis</article-title><source>Histochemistry and Cell Biology</source><volume>161</volume><fpage>29</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1007/s00418-023-02248-8</pub-id><pub-id pub-id-type="pmid">37938346</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavaliere</surname><given-names>F</given-names></name><name><surname>Dinkel</surname><given-names>K</given-names></name><name><surname>Reymann</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The subventricular zone releases factors which can be protective in oxygen/glucose deprivation-induced cortical damage: an organotypic study</article-title><source>Experimental Neurology</source><volume>201</volume><fpage>66</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2006.03.020</pub-id><pub-id pub-id-type="pmid">16750197</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavaliere</surname><given-names>F</given-names></name><name><surname>Urra</surname><given-names>O</given-names></name><name><surname>Alberdi</surname><given-names>E</given-names></name><name><surname>Matute</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Oligodendrocyte differentiation from adult multipotent stem cells is modulated by glutamate</article-title><source>Cell Death &amp; Disease</source><volume>3</volume><elocation-id>2011.144</elocation-id><pub-id pub-id-type="doi">10.1038/cddis.2011.144</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceanga</surname><given-names>M</given-names></name><name><surname>Dahab</surname><given-names>M</given-names></name><name><surname>Witte</surname><given-names>OW</given-names></name><name><surname>Keiner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Adult neurogenesis and stroke: a tale of two neurogenic niches</article-title><source>Frontiers in Neuroscience</source><volume>15</volume><elocation-id>700297</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2021.700297</pub-id><pub-id pub-id-type="pmid">34447293</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cebrian-Silla</surname><given-names>A</given-names></name><name><surname>Nascimento</surname><given-names>MA</given-names></name><name><surname>Redmond</surname><given-names>SA</given-names></name><name><surname>Mansky</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Obernier</surname><given-names>K</given-names></name><name><surname>Romero Rodriguez</surname><given-names>R</given-names></name><name><surname>Gonzalez-Granero</surname><given-names>S</given-names></name><name><surname>García-Verdugo</surname><given-names>JM</given-names></name><name><surname>Lim</surname><given-names>DA</given-names></name><name><surname>Álvarez-Buylla</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell analysis of the ventricular-subventricular zone reveals signatures of dorsal and ventral adult neurogenesis</article-title><source>eLife</source><volume>10</volume><elocation-id>e67436</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.67436</pub-id><pub-id pub-id-type="pmid">34259628</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaker</surname><given-names>Z</given-names></name><name><surname>Codega</surname><given-names>P</given-names></name><name><surname>Doetsch</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A mosaic world: puzzles revealed by adult neural stem cell heterogeneity</article-title><source>Wiley Interdisciplinary Reviews. Developmental Biology</source><volume>5</volume><fpage>640</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1002/wdev.248</pub-id><pub-id pub-id-type="pmid">27647730</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Codega</surname><given-names>P</given-names></name><name><surname>Silva-Vargas</surname><given-names>V</given-names></name><name><surname>Paul</surname><given-names>A</given-names></name><name><surname>Maldonado-Soto</surname><given-names>AR</given-names></name><name><surname>Deleo</surname><given-names>AM</given-names></name><name><surname>Pastrana</surname><given-names>E</given-names></name><name><surname>Doetsch</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prospective identification and purification of quiescent adult neural stem cells from their in vivo niche</article-title><source>Neuron</source><volume>82</volume><fpage>545</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.02.039</pub-id><pub-id pub-id-type="pmid">24811379</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cregg</surname><given-names>JM</given-names></name><name><surname>DePaul</surname><given-names>MA</given-names></name><name><surname>Filous</surname><given-names>AR</given-names></name><name><surname>Lang</surname><given-names>BT</given-names></name><name><surname>Tran</surname><given-names>A</given-names></name><name><surname>Silver</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Functional regeneration beyond the glial scar</article-title><source>Experimental Neurology</source><volume>253</volume><fpage>197</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2013.12.024</pub-id><pub-id pub-id-type="pmid">24424280</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doetsch</surname><given-names>F</given-names></name><name><surname>Caillé</surname><given-names>I</given-names></name><name><surname>Lim</surname><given-names>DA</given-names></name><name><surname>García-Verdugo</surname><given-names>JM</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Subventricular zone astrocytes are neural stem cells in the adult mammalian brain</article-title><source>Cell</source><volume>97</volume><fpage>703</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80783-7</pub-id><pub-id pub-id-type="pmid">10380923</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzwonek</surname><given-names>J</given-names></name><name><surname>Wilczynski</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CD44: molecular interactions, signaling and functions in the nervous system</article-title><source>Frontiers in Cellular Neuroscience</source><volume>9</volume><elocation-id>175</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2015.00175</pub-id><pub-id pub-id-type="pmid">25999819</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzyubenko</surname><given-names>E</given-names></name><name><surname>Manrique-Castano</surname><given-names>D</given-names></name><name><surname>Kleinschnitz</surname><given-names>C</given-names></name><name><surname>Faissner</surname><given-names>A</given-names></name><name><surname>Hermann</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Role of immune responses for extracellular matrix remodeling in the ischemic brain</article-title><source>Therapeutic Advances in Neurological Disorders</source><volume>11</volume><elocation-id>1756286418818092</elocation-id><pub-id pub-id-type="doi">10.1177/1756286418818092</pub-id><pub-id pub-id-type="pmid">30619510</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Encinas</surname><given-names>JM</given-names></name><name><surname>Michurina</surname><given-names>TV</given-names></name><name><surname>Peunova</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Tordo</surname><given-names>J</given-names></name><name><surname>Peterson</surname><given-names>DA</given-names></name><name><surname>Fishell</surname><given-names>G</given-names></name><name><surname>Koulakov</surname><given-names>A</given-names></name><name><surname>Enikolopov</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus</article-title><source>Cell Stem Cell</source><volume>8</volume><fpage>566</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2011.03.010</pub-id><pub-id pub-id-type="pmid">21549330</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>JR</given-names></name><name><surname>Herrmann</surname><given-names>JE</given-names></name><name><surname>Woo</surname><given-names>MJ</given-names></name><name><surname>Tansey</surname><given-names>KE</given-names></name><name><surname>Doan</surname><given-names>NB</given-names></name><name><surname>Sofroniew</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Reactive astrocytes protect tissue and preserve function after spinal cord injury</article-title><source>The Journal of Neuroscience</source><volume>24</volume><fpage>2143</fpage><lpage>2155</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3547-03.2004</pub-id><pub-id pub-id-type="pmid">14999065</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fawcett</surname><given-names>JW</given-names></name><name><surname>Asher</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The glial scar and central nervous system repair</article-title><source>Brain Research Bulletin</source><volume>49</volume><fpage>377</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/s0361-9230(99)00072-6</pub-id><pub-id pub-id-type="pmid">10483914</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fawcett</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The extracellular matrix in plasticity and regeneration after CNS injury and neurodegenerative disease</article-title><source>Progress in Brain Research</source><volume>218</volume><fpage>213</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/bs.pbr.2015.02.001</pub-id><pub-id pub-id-type="pmid">25890139</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frisén</surname><given-names>J</given-names></name><name><surname>Johansson</surname><given-names>CB</given-names></name><name><surname>Török</surname><given-names>C</given-names></name><name><surname>Risling</surname><given-names>M</given-names></name><name><surname>Lendahl</surname><given-names>U</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury</article-title><source>The Journal of Cell Biology</source><volume>131</volume><fpage>453</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1083/jcb.131.2.453</pub-id><pub-id pub-id-type="pmid">7593171</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelderblom</surname><given-names>M</given-names></name><name><surname>Leypoldt</surname><given-names>F</given-names></name><name><surname>Steinbach</surname><given-names>K</given-names></name><name><surname>Behrens</surname><given-names>D</given-names></name><name><surname>Choe</surname><given-names>CU</given-names></name><name><surname>Siler</surname><given-names>DA</given-names></name><name><surname>Arumugam</surname><given-names>TV</given-names></name><name><surname>Orthey</surname><given-names>E</given-names></name><name><surname>Gerloff</surname><given-names>C</given-names></name><name><surname>Tolosa</surname><given-names>E</given-names></name><name><surname>Magnus</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Temporal and spatial dynamics of cerebral immune cell accumulation in stroke</article-title><source>Stroke</source><volume>40</volume><fpage>1849</fpage><lpage>1857</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.108.534503</pub-id><pub-id pub-id-type="pmid">19265055</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girard</surname><given-names>F</given-names></name><name><surname>Eichenberger</surname><given-names>S</given-names></name><name><surname>Celio</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Thrombospondin 4 deficiency in mouse impairs neuronal migration in the early postnatal and adult brain</article-title><source>Molecular and Cellular Neurosciences</source><volume>61</volume><fpage>176</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2014.06.010</pub-id><pub-id pub-id-type="pmid">24983516</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaraj</surname><given-names>RL</given-names></name><name><surname>Azimullah</surname><given-names>S</given-names></name><name><surname>Beiram</surname><given-names>R</given-names></name><name><surname>Jalal</surname><given-names>FY</given-names></name><name><surname>Rosenberg</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neuroinflammation: friend and foe for ischemic stroke</article-title><source>Journal of Neuroinflammation</source><volume>16</volume><elocation-id>1516-2</elocation-id><pub-id pub-id-type="doi">10.1186/s12974-019-1516-2</pub-id><pub-id pub-id-type="pmid">31291966</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kjell</surname><given-names>J</given-names></name><name><surname>Fischer-Sternjak</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>AJ</given-names></name><name><surname>Friess</surname><given-names>C</given-names></name><name><surname>Sticco</surname><given-names>MJ</given-names></name><name><surname>Salinas</surname><given-names>F</given-names></name><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Martinelli</surname><given-names>DC</given-names></name><name><surname>Ninkovic</surname><given-names>J</given-names></name><name><surname>Franze</surname><given-names>K</given-names></name><name><surname>Schiller</surname><given-names>HB</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Defining the adult neural stem cell niche proteome identifies key regulators of adult neurogenesis</article-title><source>Cell Stem Cell</source><volume>26</volume><fpage>277</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.01.002</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kralic</surname><given-names>JE</given-names></name><name><surname>Ledergerber</surname><given-names>DA</given-names></name><name><surname>Fritschy</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Disruption of the neurogenic potential of the dentate gyrus in a mouse model of temporal lobe epilepsy with focal seizures</article-title><source>The European Journal of Neuroscience</source><volume>22</volume><fpage>1916</fpage><lpage>1927</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04386.x</pub-id><pub-id pub-id-type="pmid">16262631</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>LW</given-names></name><name><surname>Cua</surname><given-names>R</given-names></name><name><surname>Keough</surname><given-names>MB</given-names></name><name><surname>Haylock-Jacobs</surname><given-names>S</given-names></name><name><surname>Yong</surname><given-names>VW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Pathophysiology of the brain extracellular matrix: a new target for remyelination</article-title><source>Nature Reviews. Neuroscience</source><volume>14</volume><fpage>722</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1038/nrn3550</pub-id><pub-id pub-id-type="pmid">23985834</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laug</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>TW</given-names></name><name><surname>Huerta</surname><given-names>NAB</given-names></name><name><surname>Huang</surname><given-names>AYS</given-names></name><name><surname>Sardar</surname><given-names>D</given-names></name><name><surname>Ortiz-Guzman</surname><given-names>J</given-names></name><name><surname>Carlson</surname><given-names>JC</given-names></name><name><surname>Arenkiel</surname><given-names>BR</given-names></name><name><surname>Kuo</surname><given-names>CT</given-names></name><name><surname>Mohila</surname><given-names>CA</given-names></name><name><surname>Glasgow</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Deneen</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nuclear factor I-A regulates diverse reactive astrocyte responses after CNS injury</article-title><source>The Journal of Clinical Investigation</source><volume>129</volume><fpage>4408</fpage><lpage>4418</lpage><pub-id pub-id-type="doi">10.1172/JCI127492</pub-id><pub-id pub-id-type="pmid">31498149</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Harms</surname><given-names>KM</given-names></name><name><surname>Ventura</surname><given-names>PB</given-names></name><name><surname>Lagace</surname><given-names>DC</given-names></name><name><surname>Eisch</surname><given-names>AJ</given-names></name><name><surname>Cunningham</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Focal cerebral ischemia induces a multilineage cytogenic response from adult subventricular zone that is predominantly gliogenic</article-title><source>Glia</source><volume>58</volume><fpage>1610</fpage><lpage>1619</lpage><pub-id pub-id-type="doi">10.1002/glia.21033</pub-id><pub-id pub-id-type="pmid">20578055</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindwall</surname><given-names>C</given-names></name><name><surname>Olsson</surname><given-names>M</given-names></name><name><surname>Osman</surname><given-names>AM</given-names></name><name><surname>Kuhn</surname><given-names>HG</given-names></name><name><surname>Curtis</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Selective expression of hyaluronan and receptor for hyaluronan mediated motility (Rhamm) in the adult mouse subventricular zone and rostral migratory stream and in ischemic cortex</article-title><source>Brain Research</source><volume>1503</volume><fpage>62</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2013.01.045</pub-id><pub-id pub-id-type="pmid">23391595</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>XS</given-names></name><name><surname>Zhang</surname><given-names>ZG</given-names></name><name><surname>Zhang</surname><given-names>RL</given-names></name><name><surname>Gregg</surname><given-names>S</given-names></name><name><surname>Morris</surname><given-names>DC</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chopp</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Stroke induces gene profile changes associated with neurogenesis and angiogenesis in adult subventricular zone progenitor cells</article-title><source>Journal of Cerebral Blood Flow and Metabolism</source><volume>27</volume><fpage>564</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600371</pub-id><pub-id pub-id-type="pmid">16835628</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llorens-Bobadilla</surname><given-names>E</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Baser</surname><given-names>A</given-names></name><name><surname>Saiz-Castro</surname><given-names>G</given-names></name><name><surname>Zwadlo</surname><given-names>K</given-names></name><name><surname>Martin-Villalba</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Single-cell transcriptomics reveals a population of dormant neural stem cells that become activated upon brain injury</article-title><source>Cell Stem Cell</source><volume>17</volume><fpage>329</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2015.07.002</pub-id><pub-id pub-id-type="pmid">26235341</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>KR</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>How the extracellular matrix shapes neural development</article-title><source>Open Biology</source><volume>9</volume><elocation-id>180216</elocation-id><pub-id pub-id-type="doi">10.1098/rsob.180216</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luskin</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone</article-title><source>Neuron</source><volume>11</volume><fpage>173</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(93)90281-u</pub-id><pub-id pub-id-type="pmid">8338665</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muppala</surname><given-names>S</given-names></name><name><surname>Xiao</surname><given-names>R</given-names></name><name><surname>Krukovets</surname><given-names>I</given-names></name><name><surname>Verbovetsky</surname><given-names>D</given-names></name><name><surname>Yendamuri</surname><given-names>R</given-names></name><name><surname>Habib</surname><given-names>N</given-names></name><name><surname>Raman</surname><given-names>P</given-names></name><name><surname>Plow</surname><given-names>E</given-names></name><name><surname>Stenina-Adognravi</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Thrombospondin-4 mediates TGF-β-induced angiogenesis</article-title><source>Oncogene</source><volume>36</volume><fpage>5189</fpage><lpage>5198</lpage><pub-id pub-id-type="doi">10.1038/onc.2017.140</pub-id><pub-id pub-id-type="pmid">28481870</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>PT</given-names></name><name><surname>Dorman</surname><given-names>LC</given-names></name><name><surname>Pan</surname><given-names>S</given-names></name><name><surname>Vainchtein</surname><given-names>ID</given-names></name><name><surname>Han</surname><given-names>RT</given-names></name><name><surname>Nakao-Inoue</surname><given-names>H</given-names></name><name><surname>Taloma</surname><given-names>SE</given-names></name><name><surname>Barron</surname><given-names>JJ</given-names></name><name><surname>Molofsky</surname><given-names>AB</given-names></name><name><surname>Kheirbek</surname><given-names>MA</given-names></name><name><surname>Molofsky</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Microglial Remodeling of the extracellular matrix promotes synapse plasticity</article-title><source>Cell</source><volume>182</volume><fpage>388</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.05.050</pub-id><pub-id pub-id-type="pmid">32615087</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platel</surname><given-names>JC</given-names></name><name><surname>Angelova</surname><given-names>A</given-names></name><name><surname>Bugeon</surname><given-names>S</given-names></name><name><surname>Wallace</surname><given-names>J</given-names></name><name><surname>Ganay</surname><given-names>T</given-names></name><name><surname>Chudotvorova</surname><given-names>I</given-names></name><name><surname>Deloulme</surname><given-names>JC</given-names></name><name><surname>Béclin</surname><given-names>C</given-names></name><name><surname>Tiveron</surname><given-names>MC</given-names></name><name><surname>Coré</surname><given-names>N</given-names></name><name><surname>Murthy</surname><given-names>VN</given-names></name><name><surname>Cremer</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neuronal integration in the adult mouse olfactory bulb is a non-selective addition process</article-title><source>eLife</source><volume>8</volume><elocation-id>e44830</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.44830</pub-id><pub-id pub-id-type="pmid">31294694</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pous</surname><given-names>L</given-names></name><name><surname>Deshpande</surname><given-names>SS</given-names></name><name><surname>Nath</surname><given-names>S</given-names></name><name><surname>Mezey</surname><given-names>S</given-names></name><name><surname>Malik</surname><given-names>SC</given-names></name><name><surname>Schildge</surname><given-names>S</given-names></name><name><surname>Bohrer</surname><given-names>C</given-names></name><name><surname>Topp</surname><given-names>K</given-names></name><name><surname>Pfeifer</surname><given-names>D</given-names></name><name><surname>Fernández-Klett</surname><given-names>F</given-names></name><name><surname>Doostkam</surname><given-names>S</given-names></name><name><surname>Galanakis</surname><given-names>DK</given-names></name><name><surname>Taylor</surname><given-names>V</given-names></name><name><surname>Akassoglou</surname><given-names>K</given-names></name><name><surname>Schachtrup</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Fibrinogen induces neural stem cell differentiation into astrocytes in the subventricular zone via BMP signaling</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>14466</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-14466-y</pub-id><pub-id pub-id-type="pmid">32005867</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preston</surname><given-names>M</given-names></name><name><surname>Sherman</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neural stem cell niches: critical roles for the hyaluronan-based extracellular matrix in neural stem cell proliferation and differentiation</article-title><source>Frontiers in Bioscience</source><volume>3</volume><fpage>1165</fpage><lpage>1179</lpage><pub-id pub-id-type="doi">10.2741/218</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>JY</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: An open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segel</surname><given-names>M</given-names></name><name><surname>Neumann</surname><given-names>B</given-names></name><name><surname>Hill</surname><given-names>MFE</given-names></name><name><surname>Weber</surname><given-names>IP</given-names></name><name><surname>Viscomi</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Young</surname><given-names>A</given-names></name><name><surname>Agley</surname><given-names>CC</given-names></name><name><surname>Thompson</surname><given-names>AJ</given-names></name><name><surname>Gonzalez</surname><given-names>GA</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Holmqvist</surname><given-names>S</given-names></name><name><surname>Rowitch</surname><given-names>DH</given-names></name><name><surname>Franze</surname><given-names>K</given-names></name><name><surname>Franklin</surname><given-names>RJM</given-names></name><name><surname>Chalut</surname><given-names>KJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Niche stiffness underlies the ageing of central nervous system progenitor cells</article-title><source>Nature</source><volume>573</volume><fpage>130</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1484-9</pub-id><pub-id pub-id-type="pmid">31413369</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname><given-names>LS</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name><name><surname>Su</surname><given-names>W</given-names></name><name><surname>Srivastava</surname><given-names>T</given-names></name><name><surname>Back</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Hyaluronan synthesis, catabolism, and signaling in neurodegenerative diseases</article-title><source>International Journal of Cell Biology</source><volume>2015</volume><elocation-id>368584</elocation-id><pub-id pub-id-type="doi">10.1155/2015/368584</pub-id><pub-id pub-id-type="pmid">26448752</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silver</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Regeneration beyond the glial scar</article-title><source>Nature Reviews. Neuroscience</source><volume>5</volume><fpage>146</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1038/nrn1326</pub-id><pub-id pub-id-type="pmid">14735117</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohn</surname><given-names>J</given-names></name><name><surname>Orosco</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>F</given-names></name><name><surname>Chung</surname><given-names>SH</given-names></name><name><surname>Bannerman</surname><given-names>P</given-names></name><name><surname>Mills Ko</surname><given-names>E</given-names></name><name><surname>Zarbalis</surname><given-names>K</given-names></name><name><surname>Deng</surname><given-names>W</given-names></name><name><surname>Pleasure</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The subventricular zone continues to generate corpus callosum and rostral migratory stream astroglia in normal adult mice</article-title><source>The Journal of Neuroscience</source><volume>35</volume><fpage>3756</fpage><lpage>3763</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3454-14.2015</pub-id><pub-id pub-id-type="pmid">25740506</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soria</surname><given-names>FN</given-names></name><name><surname>Paviolo</surname><given-names>C</given-names></name><name><surname>Doudnikoff</surname><given-names>E</given-names></name><name><surname>Arotcarena</surname><given-names>ML</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Danné</surname><given-names>N</given-names></name><name><surname>Mandal</surname><given-names>AK</given-names></name><name><surname>Gosset</surname><given-names>P</given-names></name><name><surname>Dehay</surname><given-names>B</given-names></name><name><surname>Groc</surname><given-names>L</given-names></name><name><surname>Cognet</surname><given-names>L</given-names></name><name><surname>Bezard</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Synucleinopathy alters nanoscale organization and diffusion in the brain extracellular space through hyaluronan remodeling</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>17328-9</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17328-9</pub-id><pub-id pub-id-type="pmid">32651387</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Soria</surname><given-names>FN</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>Tools</data-title><version designator="swh:1:rev:ea307cd98471d7e62e53d693e9aeebfc43ee55f8">swh:1:rev:ea307cd98471d7e62e53d693e9aeebfc43ee55f8</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:ec0a9a35e1a10dd803cc31d91d743b1cbd86f9da;origin=https://github.com/SoriaFN/Tools;visit=swh:1:snp:2d5848cebc9c7b16c82a1282da4cb29c34ae98a3;anchor=swh:1:rev:ea307cd98471d7e62e53d693e9aeebfc43ee55f8">https://archive.softwareheritage.org/swh:1:dir:ec0a9a35e1a10dd803cc31d91d743b1cbd86f9da;origin=https://github.com/SoriaFN/Tools;visit=swh:1:snp:2d5848cebc9c7b16c82a1282da4cb29c34ae98a3;anchor=swh:1:rev:ea307cd98471d7e62e53d693e9aeebfc43ee55f8</ext-link></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundholm-Peters</surname><given-names>NL</given-names></name><name><surname>Yang</surname><given-names>HKC</given-names></name><name><surname>Goings</surname><given-names>GE</given-names></name><name><surname>Walker</surname><given-names>AS</given-names></name><name><surname>Szele</surname><given-names>FG</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Subventricular zone neuroblasts emigrate toward cortical lesions</article-title><source>Journal of Neuropathology and Experimental Neurology</source><volume>64</volume><fpage>1089</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1097/01.jnen.0000190066.13312.8f</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Azpurua</surname><given-names>J</given-names></name><name><surname>Hine</surname><given-names>C</given-names></name><name><surname>Vaidya</surname><given-names>A</given-names></name><name><surname>Myakishev-Rempel</surname><given-names>M</given-names></name><name><surname>Ablaeva</surname><given-names>J</given-names></name><name><surname>Mao</surname><given-names>Z</given-names></name><name><surname>Nevo</surname><given-names>E</given-names></name><name><surname>Gorbunova</surname><given-names>V</given-names></name><name><surname>Seluanov</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat</article-title><source>Nature</source><volume>499</volume><fpage>346</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1038/nature12234</pub-id><pub-id pub-id-type="pmid">23783513</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanner</surname><given-names>IB</given-names></name><name><surname>Anderson</surname><given-names>MA</given-names></name><name><surname>Song</surname><given-names>B</given-names></name><name><surname>Levine</surname><given-names>J</given-names></name><name><surname>Fernandez</surname><given-names>A</given-names></name><name><surname>Gray-Thompson</surname><given-names>Z</given-names></name><name><surname>Ao</surname><given-names>Y</given-names></name><name><surname>Sofroniew</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury</article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>12870</fpage><lpage>12886</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2121-13.2013</pub-id><pub-id pub-id-type="pmid">23904622</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>T</given-names></name><name><surname>Ninomiya</surname><given-names>M</given-names></name><name><surname>Hernández Acosta</surname><given-names>P</given-names></name><name><surname>García-Verdugo</surname><given-names>JM</given-names></name><name><surname>Sunabori</surname><given-names>T</given-names></name><name><surname>Sakaguchi</surname><given-names>M</given-names></name><name><surname>Adachi</surname><given-names>K</given-names></name><name><surname>Kojima</surname><given-names>T</given-names></name><name><surname>Hirota</surname><given-names>Y</given-names></name><name><surname>Kawase</surname><given-names>T</given-names></name><name><surname>Araki</surname><given-names>N</given-names></name><name><surname>Abe</surname><given-names>K</given-names></name><name><surname>Okano</surname><given-names>H</given-names></name><name><surname>Sawamoto</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum</article-title><source>The Journal of Neuroscience</source><volume>26</volume><fpage>6627</fpage><lpage>6636</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0149-06.2006</pub-id><pub-id pub-id-type="pmid">16775151</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>JY</given-names></name><name><surname>Boit</surname><given-names>K</given-names></name><name><surname>Ablaeva</surname><given-names>J</given-names></name><name><surname>Zakusilo</surname><given-names>FT</given-names></name><name><surname>Emmrich</surname><given-names>S</given-names></name><name><surname>Firsanov</surname><given-names>D</given-names></name><name><surname>Rydkina</surname><given-names>E</given-names></name><name><surname>Biashad</surname><given-names>SA</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Tyshkovskiy</surname><given-names>A</given-names></name><name><surname>Gladyshev</surname><given-names>VN</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name><name><surname>Seluanov</surname><given-names>A</given-names></name><name><surname>Gorbunova</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Increased hyaluronan by naked mole-rat Has2 improves healthspan in mice</article-title><source>Nature</source><volume>621</volume><fpage>196</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1038/s41586-023-06463-0</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>DR</given-names></name><name><surname>Dours-Zimmermann</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Extracellular matrix of the central nervous system: from neglect to challenge</article-title><source>Histochemistry and Cell Biology</source><volume>130</volume><fpage>635</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1007/s00418-008-0485-9</pub-id><pub-id pub-id-type="pmid">18696101</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96076.4.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Scimemi</surname><given-names>Annalisa</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University at Albany, State University of New York</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>The authors show that a middle carotid artery occlusion (MCAO) hypoxia lesion leads to hyaluronan-mediated chemoattraction to the lesion penumbra of Thbs-4-expressing astrocytes of the subventricular zone (SVZ). These findings are <bold>valuable</bold> because they shed light on the function of astrocytes from the adult SVZ in pathological states like brain ischemic injury. The results are <bold>convincing</bold> as they rely on a comprehensive analysis of experimental data.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96076.4.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The authiors show that SVZ derived astrocytes respond to a middle carotid artery occlusion (MCAO) hypoxia lesion by secreting and modulating hyaluronan at the edge of the lesion (penumbra) and that hyaluronin is a chemoattractant to SVZ astrocytes. They use lineage tracing of SVZ cells to determine their origin. They also find that SVZ derived astrocytes express Thbs-4 but astrocytes at the MCAO-induced scar do not. Also, they demonstrate that decreased HA in the SVZ is correlated with gliogenesis. While much of the paper is descriptive/correlative they do overexpress Hyaluronan synthase 2 via viral vectors and show this is sufficient to recruit astrocytes to the injury. Interestingly, astrocytes preferred to migrate to the MCAO than to the region of overexpressed HAS2.</p><p>Strengths:</p><p>The field has largely ignored the gliogenic response of the SVZ, especially with regards to astrocytic function. These cells and especially newborn cells may provide support for regeneration. Emigrated cells from the SVZ have been shown to be neuroprotective via creating pro-survival environments, but their expression and deposition of beneficial extracellular matrix molecules is poorly understood. Therefore, this study is timely and important. The paper is very well written and flow of result logical.</p><p>Comments on revised version:</p><p>Thanks for addressing my final points.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96076.4.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In their manuscript, Ardaya et al address the impact of ischemia-induced astrogliogenesis from the adult SVZ and their effect on remodeling of the extracellular matrix (ECM) in the glial scar. The authors show that the levels of Thbs4, a marker previously identified to be expressed in astrocytes and neural stem cells (NSCs) of the SVZ, strongly increase upon ischemia. While proliferation is significantly increase shortly after ischemia, Nestin and DCX (markers for NSCs and neuroblasts, respectively) decrease and Thbs4 levels suggesting that the neurogenic program is halted and astrogenesis is enhanced. By fate-mapping, the authors show that astrocytes derive from SVZ NSCs and migrate towards the lesion. These SVZ-derived astrocytes strongly express Thbs4 and populate the border of the lesion, while local astrocytes do not express Thbs4 and localize to both scar and border. Interestingly, the Thbs4-positive astrocytes appear to represent a second wave of astrocytes accumulating at the scar, following an immediate reaction of first wave reactive gliosis by local astrocytes. Mechanistically, the study presents evidence that the degradation of hyaluronan (HA), a key component of the extracellular matrix (ECM) is downregulated in the SVZ after ischemia, potentially inducing astrogliogenesis, while HA accumulation at the lesion side represents at least one signal to recruit the newly generated astrocytes. In the aim to facilitate tissue regeneration after ischemic injury, the authors propose that the Thbs4-positive astrocytes could be a promising therapeutical target to modulate the glial scar after brain ischemia.</p><p>Strengths:</p><p>This topic is timely and important since the focus of previous studies was almost exclusively on the role of neurogenesis. The generation of adult-born astrocytes has been proven in both neurogenic niches under physiological conditions, but the implicated function in pathology has not been sufficiently addressed yet.</p><p>Weaknesses:</p><p>The study presented by Ardaya et al presents good evidence that a population of astrocytes that express Thbs4 contribute to scar formation after ischemic injury. The authors demonstrate that ischemic injury increases proliferation in the SVZ, decreases neurogenesis and increases astrogenesis. However, whether astrogenesis is a result of terminal differentiation of type B cells or their proliferation remains unclear. Here, a combination of fate mapping and thymidine analogue-tracing would have been conclusively.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96076.4.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ardaya</surname><given-names>Maria</given-names></name><role specific-use="author">Author</role><aff><institution>Achucarro Basque Center for Neuroscience</institution><addr-line><named-content content-type="city">Leioa</named-content></addr-line><country>Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Tiveron</surname><given-names>Marie-Catherine</given-names></name><role specific-use="author">Author</role><aff><institution>Aix-Marseille University, CNRS</institution><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Cremer</surname><given-names>Harold</given-names></name><role specific-use="author">Author</role><aff><institution>Aix-Marseille University, CNRS</institution><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Dehay</surname><given-names>Benjamin</given-names></name><role specific-use="author">Author</role><aff><institution>IMN-CNRS UMR 5293</institution><addr-line><named-content content-type="city">Bordeaux</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Pérez-Cerdá</surname><given-names>Fernando</given-names></name><role specific-use="author">Author</role><aff><institution>Achucarro Basque Center for Neuroscience</institution><addr-line><named-content content-type="city">Leioa</named-content></addr-line><country>Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Matute</surname><given-names>Carlos</given-names></name><role specific-use="author">Author</role><aff><institution>Achucarro Basque Center for Neuroscience</institution><addr-line><named-content content-type="city">Leioa</named-content></addr-line><country>Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Soria</surname><given-names>Federico N</given-names></name><role specific-use="author">Author</role><aff><institution>Achucarro Basque Center for Neuroscience</institution><addr-line><named-content content-type="city">Leioa</named-content></addr-line><country>Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Cavaliere</surname><given-names>Fabio</given-names></name><role specific-use="author">Author</role><aff><institution>Achucarro Basque Center for Neuroscience</institution><addr-line><named-content content-type="city">Leioa</named-content></addr-line><country>Spain</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the previous reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public review):</bold></p><p>Summary:</p><p>The authors show that SVZ derived astrocytes respond to a middle carotid artery occlusion</p><p>(MCAO) hypoxia lesion by secreting and modulating hyaluronan at the edge of the lesion (penumbra) and that hyaluronan is a chemoattractant to SVZ astrocytes. They use lineage tracing of SVZ cells to determine their origin. They also find that SVZ derived astrocytes express Thbs-4 but astrocytes at the MCAO-induced scar do not. Also, they demonstrate that decreased HA in the SVZ is correlated with gliogenesis. While much of the paper is descriptive/correlative they do overexpress Hyaluronan synthase 2 via viral vectors and show this is sufficient to recruit astrocytes to the injury. Interestingly, astrocytes preferred to migrate to the MCAO than to the region of overexpressed HAS2.</p><p>Strengths:</p><p>The field has largely ignored the gliogenic response of the SVZ, especially with regards to astrocytic function. These cells and especially newborn cells may provide support for regeneration. Emigrated cells from the SVZ have been shown to be neuroprotective via creating pro-survival environments, but their expression and deposition of beneficial extracellular matrix molecules is poorly understood. Therefore, this study is timely and important. The paper is very well written and the flow of results logical.</p><p>Comments on revised version:</p><p>The authors have addressed my points and the paper is much improved. Here are the salient remaining issues that I suggest be addressed.</p></disp-quote><p>We appreciate the feedback by the reviewer, and we are glad that the paper is considered to be much improved. We have done our best to address the remaining issues in this 2nd revision.</p><disp-quote content-type="editor-comment"><p>The authors have still not shown, using loss of function studies, that Hyaluronan is necessary for SVZ astrogenesis and or migration to MCAO lesions.</p></disp-quote><p>This is true. Unfortunately, complete removal of hyaluronan (via Hyase) triggers epilepsy, already described in 1963 by James Young (<italic>Exp Neurol</italic> paper). Degradation by Hyase also provokes neuroinflammation (Soria et al., 2020 Nat Commun). Two alternatives could be (1) partial depletion with Has inhibitor 4MU (but it is also associated with increased inflammation) or (2) a Has-KO mouse, such as Has3-/- (Arranz et al., 2014), although, to our knowledge, this mouse line is not openly available. We have added a sentence in line 332 addressing this shortcoming: “Loss-of-function studies, using HA-depletion models or HA synthase (Has)deficient mice are still needed to corroborate this finding, although the inflammation associated with HA deficiency might confound interpretation.”</p><disp-quote content-type="editor-comment"><p>(1) The co-expression of EGFr with Thbs4 and the literature examination is useful.</p></disp-quote><p>We thank the reviewer for the kind comment.</p><disp-quote content-type="editor-comment"><p>(2) Too bad they cannot explain the lack of effect of the MCAO on type C cells. The comparison with kainate-induced epilepsy in the hippocampus may or may not be relevant.</p></disp-quote><p>As stated in the previous response, we also found this interesting, and it does warrant further exploration by looking into possible direct NSC-astrocyte differentiation. But we believe that both this possible direct differentiation and the reactive status for these astrocytes are out of the scope of the study. We will not speculate about this in the discussion, either.</p><disp-quote content-type="editor-comment"><p>(3) Thanks for including the orthogonal confocal views in Fig S6D.</p><p>(4) The statement that &quot;BrdU+/Thbs4+ cells mostly in the dorsal area&quot; and therefore they mostly focused on that region is strange. Figure 8 clearly shows Thbs4 staining all along the striatal SVZ. Do they mean the dorsal segment of the striatal SVZ or the subcallosal SVZ? Fig. 4b and Fig 4f clearly show the &quot;subcallosal&quot; area as the one analysed but other figures show the dorsal striatal region (Fig. 2a). This is important because of the well-known embryological and neurogenic differences between the regions.</p></disp-quote><p>While it is true that Thbs4 is also expressed in the other subregions of the SVZ (lateral, ventral and medial), as observed in Fig 8. we chose the dorsal area because it is the subregion where we observed the larger increase in slow proliferative NSCs (Thbs4/GFAP/BrdU-positive cells) after MCAO (Fig S3). As observed in the quantifications in Fig S3, we found Thbs4/GFAP/BrdUpositive cells increase in lateral, medial and ventral SVZ, but it is not significant. Therefore, from Fig 4 onwards, we focused on the dorsal SVZ, which the reviewer mentions as “subcallosal” area. We chose the term “dorsal” as stated in single-cell studies (Cebrian-Silla et al, 2021, eLife; Marcy et al., 2023, Sci Adv) and reviews (Sequerra 2014 Front Cell Neurosci) that investigate or mention this subregion, respectively. In the abstract, we are perfectly clear stating that newborn astrocytes migrate frm both dorsal and medial areas.</p><p>In Fig 2a, the immunofluorescence image shows medial and lateral SVZ, but at this point in the paper, we have not yet made specific subregional quantifications, and the Nestin, DCX and Thbs4 quantifications refer to the SVZ as a whole, both in the IF and in the WB (Fig 2e-g). We apologize for the confusion. We have clarified this in the text (line 119).</p><disp-quote content-type="editor-comment"><p>(5) It is good to know that the harsh MCAO's had already been excluded.</p><p>(6) Sorry for the lack of clarity - in addition to Thbs4, I was referring to mouse versus rat Hyaluronan degradation genes (Hyal1, Hyal2 and Hyal3) and hyaluronan synthase genes (HAS1 and HAS2) in order to address the overall species differences in hyaluronan biology thus justifying the &quot;shift&quot; from mouse to rat. You examine these in the (weirdly positioned) Fig. 8h,i. Please add a few sentences on mouse vs rat Thbs4 and Hyaluronan relevant genes.</p></disp-quote><p>We thank the reviewer for these remarks. We have now added a sentence pointing to the similar internalization and degradation in rat and mouse (reviewed by Sherman et al., 2015). This correction is in line 233. Hyaluronan is, in evolutionary terms, a very “old” molecule, part of the “ancient” glycan-based matrix, before the evolution of proteoglycans and fibrous proteins such as collagen, laminin etc. Hence, its machinery is highly conserved across species.</p><p>We have also reorganized the panels in Fig 8, where 8h and 8i were indeed weirdly positioned. We hope that the new version of this figure is more easily readable.</p><disp-quote content-type="editor-comment"><p>(7) Thank you for the better justification of using the naked mole rat HA synthase.</p><p><bold>Reviewer #3 (Public review):</bold></p><p>Summary:</p><p>The authors aimed to study the activation of gliogenesis and the role of newborn astrocytes in a post-ischemic scenario. Combining immunofluorescence, BrdU-tracing and genetic cellular labelling, they tracked the migration of newborn astrocytes (expressing Thbs4) and found that Thbs4-positive astrocytes modulate the extracellular matrix at the lesion border by synthesis but also degradation of hyaluronan. Their results point to a relevant function of SVZ newborn astrocytes in the modulation of the glial scar after brain ischemia. This work's major strength is the fact that it is tackling the function of SVZ newborn astrocytes, whose role is undisclosed so far.</p><p>Strengths:</p><p>The article is innovative, of good quality, and clearly written, with properly described Materials and Methods, data analysis and presentation. In general, the methods are designed properly to answer the main question of the authors, being a major strength. Interpretation of the data is also in general well done, with results supporting the main conclusions of this article.</p><p>In this revised version, the points raised/weaknesses were clarified and discussed in the article.</p><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><p>Minor points:</p><p>(1) Thanks for the clarification.</p><p>(2) Thanks for the clarification.</p><p>(3) The magnification is not apparent in Fig. 5.</p></disp-quote><p>We had removed two brain slices (from 4 to 2) in order to increase the size of the image 2-fold. We have now further increased the TTC panel, 25% from the revised version, 125% from the original.</p><disp-quote content-type="editor-comment"><p>(4) Thanks for the clarification.</p><p>(5) Thanks for the clarification.</p><p>(6) Thanks for the clarification.</p><p>(7) Thanks for the clarification.</p><p>(8) Thanks for the clarification.</p></disp-quote></body></sub-article></article>